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 Urge urinary incontinence (UUI) disproportionately affects older women and 
adversely affects health related quality of life. Current medications have dangerous side 
effects in the older adult population, including falls and confusion. Older adult women 
with UUI are not sufficiently treated with current practices. 
There were three aims to this research. 1) To determine the research feasibility of 
a randomized controlled trial (RCT) comparing mindfulness-based stress reduction 
(MBSR) and the health enhancement program (HEP) in older adult women presenting 
with UUI, measured by recruitment, retention, and treatment fidelity. 2) To determine the 
intervention feasibility of an RCT comparing MBSR and HEP in older adult women 
presenting with UUI, measured by acceptability, tolerability, and treatment adherence. 
Finally, there was an exploratory aim 3) to evaluate short term preliminary efficacy of 
MBSR for treatment of UUI in older adult women, in comparison to HEP, measured by 
symptom severity, symptom bother, perceived stress, perceived self-efficacy, and the 
trajectory of change. 
Twenty-five postmenopausal women were recruited. Interested women were 
screened and subsequently enrolled, then randomized into one of two therapeutic 
(nonsurgical, nonpharmacological) approaches. They completed an 8-week intervention, 
remaining blinded to condition.  
A wide scope of feasibility determinants were examined—research: recruitment, 
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retention, and treatment fidelity; intervention: acceptability, tolerability, and treatment 
adherence. All were successfully met. Additionally, severity, bother, perceived stress, 
perceived self-efficacy, and the rate and trajectory of change were examined in the 
exploratory aim. Participants saw significant improvement in all five areas.  
This study supports prior research suggesting potential efficacy of MBSR and 
elements of HEP in treating UUI in older adult women. Study findings contribute to our 
understanding of the complex condition of UUI in an older, more vulnerable and 
underrepresented population.  
These study findings support the merit of future research in larger scale and/or 
multisite trials. In addition, development and evaluation of a combined MBSR and HEP 
therapy to address UUI in older adult women is hypothesized to produce higher efficacy 



















The longer I live, the more beautiful life becomes.  
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Urge urinary incontinence is a highly troubling condition affecting as many as 
50% of women 60 and older. This reported number may be underestimated, as only one 
in four women seek treatment for the condition. Urge urinary incontinence is more 
difficult to treat than stress urinary incontinence, and its challenging effects are seen 
across the spectrum of a woman’s life, from emotional health to sexual activity. While 
stress urinary incontinence is typically resolved with physical therapy or surgery, urge 
urinary incontinence proves more refractory to many common urinary incontinence 
treatments. However, urge urinary incontinence may respond to noninvasive mind-body 
interventions, as this study explores.  
 
1.1 Urinary Incontinence 
1.1.1 Definition 
Urinary incontinence is a lower urinary tract syndrome defined as the inability to 
hold urine in the bladder because voluntary control is lost, resulting in involuntary 
leakage (Abrams, Cardozo, et al., 2003; “Urinary incontinence,” 2015). Urinary 
incontinence is one of the foremost geriatric syndromes, and yet it is underreported to 
health care providers (Ham, Sloane, Warshaw, Potter, & Flaherty, 2014; Mitteness, 
1990). It is an undertreated syndrome in geriatric nursing facilities (Berlowitz, Brand, & 
Perkins, 1999; Lawhorne, Ouslander, Parmelee, Resnick, & Calabrese, 2008). While 
urinary incontinence is not a normal part of aging, it is often mistakenly assumed to be so 
(Doshi et al., 2010).  
Urinary incontinence is typically classified by type: stress incontinence, urge 
incontinence, or “mixed,” which is a combination of both stress and urge. Stress and urge 
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incontinence are clinically differentiated by a series of simple questions about urgency 
and physical activity (Brown et al., 2006; Holroyd-Leduc, Tannenbaum, Thorpe, & 
Straus, 2008; Rohr, Christensen, Ulstrup, & Kragstrup, 2004). Stress incontinence is 
characterized by leakage resulting from increased pressure on the bladder, for example, 
upon exertion, sneezing/coughing, or jumping (Haylen et al., 2010). The cause of stress 
incontinence is quite straightforward: It occurs when the pelvic floor muscle, or the 
urethral sphincter muscle at the neck of the bladder, is weakened (A. Deneris, personal 
communication, September 9, 2017). This is a structural disorder. 
Urge incontinence is associated with a sudden need to urinate, and insufficient 
time to void in the toilet (Dumoulin & Hay-Smith, 2010). Typical precipitating events of 
urge incontinence are washing one’s hands, the sound of running water, or a familiar 
sight or action signaling home—a garage door or unlocking the door to one’s home. In 
the instance of a patient presenting with mixed urinary incontinence, one type is noted as 
predominant, for example, urinary incontinence, urge predominant. In this situation, the 
predominant type should be treated first (Thuroff et al., 2011).  
Urge urinary incontinence is part of a larger constellation of symptoms, called 
overactive  bladder, which includes urge frequency as well as nocturia (waking in the 
night due to need to urinate), but may or may not include incontinence (Abrams, 
Anderson, et al., 2010; Abrams, Cardozo, et al. 2003). The terms are sometimes used 
interchangeably, although this usage is often imprecise, since two-thirds of those with 
overactive bladder do not have urinary incontinence (Abrams, Cardozo, et al., 2003; 
Demaagd & Davenport, 2012). The most common type of urinary incontinence in older 
adults is urge urinary incontinence (Buckley, Lapitan, & Epidemiology Committee of the 
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Fourth International Consultation on Incontinence, 2010). The generally recognized 
definition of an older adult is an adult aged 65 or older (Gorman, 1999).  
 
1.1.2 Prevalence 
Urge urinary incontinence is common among the older adult population; up to 
50% of those 60 and older report symptoms of urge urinary incontinence (Goode, Burgio, 
Richter, & Markland, 2010). Further, data indicate that only 1 of 4 women with urge 
urinary incontinence seek care (Minassian, Yan, Lichtenfeld, Sun, & Stewart, 2012). 
Urge urinary incontinence disproportionately affects older women and adversely affects 
health related quality of life (Coyne, Sexton, et al., 2008; Nitti, 2001). The effect of race 
and ethnicity on prevalence of urinary incontinence in older adult women is inconclusive, 
although at least one study has shown it is most prevalent in people of European descent, 
followed by people of Asian descent, and then people of African descent (Townsend, 
Curhan, Resnick, & Grodstein, 2010). In men, specifics regarding the incidence and 
severity of urinary incontinence over time are not well known (Ham et al., 2014). Urinary 
incontinence in men is increasing rapidly, as it correlates with surgical side effects of 
prostate cancer treatment (Ham et al., 2014). No data exist on the association of race and 
ethnicity on prevalence in the older adult male population (Goode et al., 2008; Tennstedt, 
Link, Steers, & McKinlay, 2008). This study focuses exclusively on urge urinary 







Urge urinary incontinence is also potentially traumatic, as it affects almost all 
areas of a woman’s life (Markland, Richter, Fwu, Eggers, & Kusek, 2011). Involuntary 
leakage of urine affects one’s social life, sexual activity, emotional well-being, health 
related quality of life, and risk for isolation (Bartoli, Aguzzi, & Tarricone, 2010; Coyne, 
Kvasz, et al., 2012; Coyne, Sexton, et al., 2008; Sims, Browning, Lundgren-Lindquist, & 
Kendig, 2011). Unlike stress urinary incontinence, which can typically be treated 
effectively with either physical therapy or surgery, urge urinary incontinence is more 
difficult to treat. This difficulty is alternately ascribed to detrusor muscle dysfunction or 
possible neural misregulation in the lower urinary tract (Banakhar, Al-Shaiji, & 
Hassouna, 2012). Symptoms of urge urinary incontinence can be the decisive factor that 
keeps older women from living independently: Over half of nursing facility admissions 
are related to incontinence (Coyne, Zhou, Thompson, & Versi, 2003). Thus, it may be 
particularly important to focus urge urinary incontinence research on the older adult 
female population.  
 
1.1.4 Cost 
Urinary incontinence is a costly chronic condition, estimated to reach $83 billion 
by 2020 in the United States (Ganz et al., 2010; Milsom et al., 2014; Onukwugha et al., 
2009). Cost is realized in a litany of ways: health care visits, diagnostic procedures, pads, 
behavioral therapies, pharmacotherapy, over the counter medications, sacral 
neuromodulation (the stimulation of the sacral nerves, through a surgical implant, 
allowing the person to perceive bladder fullness and completely empty the bladder) 
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(Hassouna, 2000; Elneil, 2012), surgery, caregiving, and relocation (Berlowitz et al., 
1999; Cassells & Watt, 2003; Chong, Khan, & Anger, 2011; Coyne et al., 2014).  
The cost of urge urinary incontinence affects the individual, the health system, the 
insurance structure and corporations, and long-term care facilities. Other less tangible 
costs are difficult to measure but still significant, including the eventual costs of social 
withdrawal and resulting isolation. These effects are realized across the age spectrum, 
from younger working women to community dwelling older adults and to those in 
nursing facilities (Bogner et al., 2002; Dubeau, Simon, & Morris, 2006; Fitzgerald, 
Palmer, Kirkland, & Robinson, 2002). 
 
1.1.5 Significance 
Beyond the areas of impact and cost discussed above, significance of a study to 
compare complementary treatment methods for older adult women with urge urinary 
incontinence is bolstered by the National Center for Complementary and Integrative 
Health’s (NCCIH) 2016 strategic plan. The new plan includes such relevant objectives as 
“advance understanding of the mechanisms through which mind and body approaches 
affect health, resilience, and well-being” and “conduct studies in ‘real world’ clinical 
settings to test the safety and efficacy of complementary health approaches, including 
their integration into health care” (NCCIH, 2016, p. 5).  
In addition to aligning with NCCIH’s 2016 strategic plan, this study is also 
responsive to the Institute of Medicine’s (now, National Academy of Sciences) 100 
Initial Priority Topics for Comparative Effectiveness Research (2009) second quartile call 
to “compare the effectiveness of mindfulness-based interventions… in treating… chronic 
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diseases” (p. 3). It is time to address this chronic condition in an innovative way. New 
insights gained through this research will translate into new approaches to managing 
UUI, a highly prevalent and incommodious condition in older adult women.  
 
1.2 Problem Statement 
Older adult women with urge urinary incontinence are not sufficiently treated 
with current practices.  
 
1.3 Purpose of the Study 
The purpose of this study is to examine the feasibility of conducting a pilot 
randomized controlled trial comparing mindfulness-based stress reduction with the health 
enhancement program on symptoms of urge urinary incontinence in older adult women 
and to establish preliminary efficacy of these two approaches on symptoms of urge 
urinary incontinence.  
 
1.4 Organization of Dissertation 
This dissertation consists of eight chapters: The Introductory chapter, the 
Literature Review chapter, the Literature Review article, the Methods chapter, the 
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Urge urinary incontinence (UUI) in older adult women is a distressing and 
understudied problem. UUI is correlated with “significant morbidity and reduced quality 
of life” (DeMaagd, 2012, p. 345). While it is associated with aging, it is often not 
documented at time of hospital discharge and is a neglected syndrome in care facilities as 
it is assumed to be a normal part of growing older. UUI also carries a social stigma, often 
causing those with the condition to withdraw from social opportunities, inflicting 
additional isolation during a vulnerable period of life.  
 
2.1 Urge Urinary Incontinence 
2.1.1 Risk Factors and Etiology 
The susceptibility and severity of UUI have been discussed in the introductory 
chapter. It is also important to understand the risk factors, etiology, and characteristics of 
this condition. Risk factors for urinary incontinence include age, female gender, obesity, 
depression, diabetes, hysterectomy, and functional impairment (DuBeau, Kuchel, & 
Johnson, 2009; Melville, Katon, Delaney, & Newton, 2005). Historically, urge urinary 
incontinence has been understood to be caused by bladder dysfunction, poor muscle tone 
in the pelvic floor, obesity, nerve dysfunction, or a combination of these (Andersson, 
2002; Fowler, Griffiths, & de Groat, 2008; Griffiths, Tadic, Schaefer, & Resnick, 2007; 
Subak et al., 2009). While these causes may explain some urge urinary incontinence, they 
do not account for all cases. Recent research suggests that urge urinary incontinence may 
be due to abnormal function within the brain, rather than within the nervous system or 
bladder (Baker, Costa, Guarino, & Nygaard, 2014; Baker, Costa, & Nygaard, 2012). Urge 
urinary incontinence is, to some degree, a functional rather than a structural disorder, 
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resulting from an “abnormal perception or interpretation of physiologic events” (Baker et 
al., 2014, p. 143). In a pilot study and a subsequent randomized pilot study, Baker and 
colleagues found that mindfulness-based stress reduction training significantly reduced 
leakage episodes per day, overactive bladder symptoms, and health related quality of life 
(Baker et al., 2014). Impressively, these results were maintained at 1-year follow-up. 
These findings invite the exploration of relevant variables and the relationships between 
them. 
 
2.1.1.1 Characteristics  
Urge urinary incontinence is measured by two basic symptoms, severity and 
bother. These are discrete from one another, and are measured separately. Many 




The severity of urinary incontinence escalates with age (Hannestad, Rortveit, 
Sandvik, Hunskaar, & Norwegian, 2000). Symptom severity of urge urinary incontinence 
is measured by episodes of leakage per day. This can be measured by having the patient 
complete a voiding diary, which is a record of when the leakage occurred, under what 
conditions, and the estimated amount of leakage (J. Baker, personal communications, 
October 2015). The Incontinence Severity Index can also be administered to assess 
symptom severity (Hanley, Capewell, & Hagen, 2001; Klovning, Avery, Sandvik, & 
Hunskaar, 2009). It shows good validity and adequate internal consistency (α = 0.76) 
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(Black, Griffiths, & Pope, 1996; Murphy et al., 2006). 
  
2.1.1.1.2 Bother  
Distinct from urge urinary incontinence symptom severity is the concept of 
bother. Bother is defined as the impact that urge urinary incontinence has on the 
individual (FitzGerald, Butler, Shott, & Brubaker, 2002). The experience of bother 
should not be dismissed as its effects are impactful on the individual’s quality of life (Oh 
& Ku, 2007; Penson, 2013; Sexton et al., 2011; van der Vaart, de Leeuw, Roovers, & 
Heintz, 2002). Unfortunately, older women often resign themselves to their urge urinary 
incontinence symptoms, assuming that the syndrome is inevitable and unsolvable. This 
perception can lead to a restricted lifestyle and eventual loss of autonomous living 
arrangements (Gaugler, Duval, Anderson, & Kane, 2007; Morrison & Levy, 2006). 
Bother can specifically be measured by measuring health related quality of life in urge 
urinary incontinent patients (Coyne et al., 2003). Bother is measured by administering the 
Overactive Bladder Questionnaire; in older adult populations, the Short Form is typically 
utilized (Abrams, Smith, & Cotterill, 2015; Kwak, Kwon, & Kim, 2015; Tang et al., 
2014) or the Patient Global Impression of Improvement scale (Srikrishna, Robinson, & 
Cardozo, 2010).   
 
2.1.1.2 Treatments  
Current clinical management of urge urinary incontinence is achieved in a ladder-
wise fashion (Hersh & Salzman, 2013). Cognitive behavioral therapy, such as bladder 
training, is generally the first prescribed method. If this is not sufficient in treating 
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symptoms, pharmacologic avenues are explored. Behavioral and pharmacologic therapies 
may also be combined, and this may increase treatment success. Further medical 
treatments have also been utilized. Finally, some complementary and integrative 
therapies are being explored to treat urge urinary incontinence. Unfortunately, current 
treatment effects are modest, and gaps in the literature that guides women’s treatment 
choices are wide. Long term follow-up data on treatment effects are weak or absent, and 
potential harm and side effects are not well described (Hartmann et al., 2009).  
 
2.1.1.2.1 Behavioral Therapy  
The current first line of treatment for urge urinary incontinence is behavioral 
therapy. Behavioral therapy may consist of education, biofeedback, use of voiding 
diaries, scheduling or postponing voiding, avoiding caffeine use, or strengthening the 
pelvic floor (Burgio, 2009; Cardozo, 2000; Dumoulin & Hay-Smith, 2010; Milne, 2008; 
Wang, 2000; Wang, Wang, & Chen, 2004; Wyman, Burgio, & Newman, 2009). Several 
studies have shown reduction of symptoms with behavioral therapy programs, although 
participant satisfaction rates varied (Burgio et al., 2002; Diokno et al., 2004; Dumoulin & 
Hay-Smith, 2010; Wyman et al., 2009). Behavioral therapy has a few caveats: Adherence 
tends to be low, there are few skilled practitioners who offer it, it requires many visits, 
and as such can be both time consuming and expensive (I. Nygaard, personal 
communication, 23 November 2015). Behavioral therapies reportedly reduce leakage 





2.1.1.2.2 Pharmacologic Therapy  
Pharmacologic treatments are designed to be a second line of treatment (Nabi, 
Cody, Ellis, Herbison, & Hay-Smith, 2006). The most common class of medications used 
for urge urinary incontinence treatment is anticholinergics. Anticholinergics block 
acetylcholine (muscarinic) signals to the brain, which trigger the abnormal contractions 
associated with urge urinary incontinence. Anticholinergic medications reduce the 
number of leakage episodes to between 1.5–2.5 per day (Hartmann et al., 2009). These 
medications are designed to relax the bladder, yet side effects and contraindications are 
numerous and often dangerous. High rates of discontinuation in patients taking 
anticholinergics are reported, not only in older adult women but younger women and men 
as well (Gopal, Haynes, Bellamy, & Arya, 2008). Serious central nervous system side 
effects, including falls, confusion, sleep disruption and psychosis, are often seen in 
patients taking anticholinergic medication (Franco, 2011). These unwelcome 
anticholinergic side effects are more troubling in an older population, where a serious fall 
or confusion threatens the independence of the individual. Both older age and female 
gender are significantly associated with adverse drug reaction related hospital 
admissions; as such, pharmacologic treatment carries more severe risk for older adult 
women (Mannesse, Derkx, De Ridder, & van der Cammen, 2000). Additionally, these 
medications tend to show reduced efficacy with long-term use (Kelleher, Cardozo, 
Khullar, & Salvatore, 1997). Hence, older adult women are a crucial population in which 





2.1.1.2.3 Combined Therapy  
Regrettably, neither behavioral nor pharmaceutical treatments delivers reliable, 
satisfactory long-term outcomes; in fact, a single management modality is not likely to 
entirely resolve women’s symptoms of urge urinary incontinence (Hartmann et al., 2009). 
Behavioral therapy and pharmacologic therapy are often used in conjunction to treat urge 
urinary incontinence (Borello-France et al., 2010; Burgio et al., 2010; Goode et al., 2011; 
Wyman, Harding et al., 2010; Wyman, Klutke et al., 2010). A Cochrane review of 
anticholinergics versus nonpharmacological therapies for overactive bladder syndrome 
reported that better results (e.g., fewer leakage episodes) were reported when 
pharmacologic and behavior therapy were used in tandem (Alhasso, McKinlay, Patrick, 
& Stewart, 2006). In contrast, a more recent RCT showed lack of improvement when 
adding behavioral therapy to an existing pharmacologic treatment regimen (Burgio et al., 
2010).While care providers may use behavioral therapy to wean a patient off of 
medication, a recent study showed unsustained satisfaction with behavior treatment after 
discontinuation of pharmacologic treatment (Burgio, 2009; Burgio et al., 2008; Milne, 
2008).  
 
2.1.1.2.4 Further Therapies  
When urge urinary incontinence proves refractory to medication and behavioral 
therapies, other alternative medical therapies are explored. However, many of these 
therapies have been found to be invasive and not efficacious. One such treatment is the 
use of botulinum toxin A (Botox®; Petrou et al., 2009; Shepherd, Lowder, Leng, & 
Smith, 2011; Visco et al., 2012). The main concern with this treatment is that as many as 
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half of patients are left with “transient post-void residual urine increase,” which is a 
severe, negative side effect (Brubaker et al., 2008). A 2008 systematic review found 
“clinically significant improvement,” although it called for more appropriately powered 
and designed studies. In addition, several of the article’s authors are consultants for 
Allergan, the company that produces Botox® (Karsenty et al., 2008). A later study also 
found this same negative side effect of transient urinary retention as well as a higher rate 
of urinary tract infections as compared to anticholinergic therapy (Visco et al., 2012). 
Another treatment is neuromodulation of sacral nerves, which has shown encouraging 
outcomes in women of all ages, ranged 17–81 years old (Abrams, Cardozo, et al., 2003; 
Hassouna et al., 2000; Siegel et al., 2000). Still, sacral neuromodulation is an invasive 
and expensive treatment option for urge urinary incontinence, and complications include 
patient pain at the site of implantation as well as lead migration (Schmidt et al., 1999). 
Several authors, including Shamliyan, Kane, Wyman, and Wilt in their systematic 
review, concur that the effects of sacral modulation and botulism injections are 
inconsistent and the current indications are not sufficient to guide selection for patients 
with urge urinary incontinence (Hartmann, 2009; Shamliyan, Kane, Wyman, & Wilt, 
2008). 
 
2.1.1.2.5 Complementary and Integrative Therapy  
Complementary health practices refer to individualized, holistic treatments which 
use natural medicinal products developed outside of conventional medicine, and/or 
nonpharmacologic therapies such as acupressure or massage (Kienle et al., 2011). These 
are systems, products, and practices “not generally considered part of conventional 
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medicine” (“Complementary,” 2015). The National Center for Complementary and 
Integrative Health, a division of the National Institutes of Health, and formerly named the 
National Center for Complementary and Alternative Medicine, uses the term 
complementary health approaches when “discuss[ing] practices and products of 
nonmainstream origin,” while the term integrative health is used to describe 
“incorporating complementary approaches into mainstream health care” 
(“Complementary,” 2015). It is estimated that approximately 11% of Americans’ health 
care costs are spent on complementary and integrative health practices, products, or 
services (Nahin et al., 2007).  
It is uncertain how frequently complementary and integrative therapies have been 
used to treat urge urinary incontinence, but investigations of these approaches are 
becoming more common in the scientific literature. Potential complementary, integrative, 
and alternative therapies have not yet been sufficiently studied for definitive 
recommendations to be made (Cherniack, 2006).  
Acupuncture for overactive bladder has been studied in a pilot study, a 
randomized controlled trial, and most recently in a review, by separate research teams 
(Bergstrom, Carlsson, Lindholm, & Widengren, 2000; Emmons & Otto, 2005; Paik et al., 
2013). The pilot study found “significant improvements” (Bergstrom et al. 2000, p. 179) 
after 12 acupuncture treatments, with improvement sustained at 3-month follow-up. This 
study did not include a control condition. The randomized controlled trial showed 
decreases in episodes of incontinence in both the treatment and placebo conditions but 
saw “no significant difference in the change between the groups” (Emmons & Otto, 
2005, p. 138). The review examined several RCTs and found that the results “failed to 
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demonstrate any statistically significant improvements in urinary incontinence” (Paik et 
al., 2013). 
Elstad and colleagues (2011) report that Hispanic populations use herbal drinks to 
treat urinary incontinence. Loera and colleagues (2001) show that Hispanics most 
commonly using herbs are female, older than 75, living independently, and experiencing 
financial strain. Typical drinks include agua fresca, maize silk, and horsetail. The use of 
these herbal medicines has not been shown to reduce urinary symptoms (Elstad, 
Maserejian, McKinlay, & Tennstedt, 2011; Loera, Black, Markides, Espino, & Goodwin, 
2001). 
Two recent studies explored the practice of yoga in treating urge urinary 
incontinence in women, although not specifically in older adults (Huang, Jenny, Chesney, 
Schembri, & Subak, 2014; Tenfelde & Janusek, 2014). Huang and colleagues 
administered a yoga intervention and saw overall incontinence reduced by 66% in the 
yoga condition compared with 13% in the waitlist control condition, but these 
improvements were only observed in the stress incontinent participants (Huang et al., 
2014). No significant reduction in episodes of incontinence were observed in the urge 
incontinent participants.  
In an earlier study, an autonomic nervous system imbalance was detected in 
women with overactive bladder syndrome (OAB), of which urge urinary incontinence is 
a part (Hubeaux, Deffieux, Ismael, Raibaut, & Amarenco, 2007). Specifically, 
sympathetic tone “increased significantly in women with OAB at the end of bladder 
filling,” while in women with stress urinary incontinence, it did not. Women with urge 
urinary incontinence presented with this autonomic nervous system imbalance while 
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women with stress urinary incontinence displayed autonomic nervous system balance. 
Two subsequent studies reproduced this autonomic nervous system difference between 
urge urinary incontinent and stress urinary incontinent participants (Hubeaux et al., 2011; 
Im, Kim, Kim, & Choi, 2010). Tenfelde and Janusek discussed the possibility that 
meditative approaches may correct this autonomic nervous system imbalance that women 
with urge urinary incontinence have been shown to have (Tenfelde & Janusek, 2014).  
Various treatments have been applied to the urge urinary incontinent older adult 
female population. Traditionally, behavioral and/or pharmacologic therapies have been 
prescribed, recommended, or administered. The decreasing efficacy of pharmacologic 
treatment and the tendency for women with urge urinary incontinence to need to involve 
multicomponent behavioral therapy indicate a need for new, more effective treatment 
options (Hartmann et al., 2009; Tenfelde & Janusek, 2014).  
 
2.1.2 Problem Statement  
Older adult women with urge urinary incontinence are not sufficiently treated 
with current practices.  
 
2.2 Theoretical Framework 
To explore promising potential treatments for urge urinary incontinence, it is 
important to examine the mental and emotional factors of urge urinary incontinence. The 
psychological component of urge urinary incontinence can be viewed through the lens of 
two theories: stress process theory and the concept of self-efficacy. Stress process theory, 
as defined by Pearlin and colleagues, has a role in explaining why women persistently 
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experience urge urinary incontinence (Pearlin, Lieberman, Menaghan, & Mullan, 1981; 
Pearlin, Schieman, Fazio, & Meersman, 2005). The concept of self-efficacy, developed 
by Albert Bandura, may explain how a mind–body treatment could reduce the symptoms 
and impact of urge urinary incontinence (Bandura, 1977, 1990, 2004; Bandura, Caprara, 
Barbaranelli, Gerbino, & Pastorelli, 2003; Bandura, Cioffi, Taylor, & Brouillard, 1988; 
Bandura & Locke, 2003). These two theories offer context for possible efficacious 
treatment of urge urinary incontinence.  
 
2.2.1 Stress Process Theory  
The Oxford English Dictionary (Simpson, Weiner, & Oxford University, 1989) 
defines stress as, “An adverse circumstance that disturbs, or is likely to disturb, the 
normal physiological or psychological functioning of an individual; such circumstances 
collectively. Also, the disturbed state that results.” Stress process theory posits that 
people develop stress when they are exposed to chronic strain and undergo eventful 
experiences, and that this stress results in negative health outcomes (Pearlin et al., 1981; 
Pearlin et al., 2005). Stress process theory has been applied to explain correlations in 
health disparities and socioeconomic status (McEwen & Gianaros, 2010; Thoits, 2010; 
Turner, 2010). Gender inequalities can magnify people’s exposure to stress (Thoits, 
2010). While short-term stress process can be protective, long-term stress process is 
typically damaging; conditions which are chronically stressful cause deterioration in both 
brain and body (McEwen & Gianaros, 2010). Older adults are often exposed to long-term 
stress in the form of loss of relationships, social status, and/or job identity. The negative 
effects may then be seen in both mind and body. Stress process theory may be used to 
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explain the mind–body connection of stress to urge urinary incontinence, and, as eventful 
change is unavoidably part of the aging process, may be particularly applicable to the 
experience in older adult women.  
Stress has both psychological and physical consequences. The mental and 
emotional strain of stress, psychological in nature, can express itself physiologically. Lai 
and colleagues (2015) measured psychological stress in urinary incontinent individuals 
and found that participants with overactive bladder had psychological stress levels 
significantly higher than healthy controls (Lai, Gardner, Vetter, & Andriole, 2015). 
Psychological stress in this study was measured with the Perceived Stress Scale (Cohen, 
Kamarck, & Mermelstein, 1983). This study showed a positive correlation between stress 
levels and symptoms of urinary incontinence (p = .007) and impact on quality of life (p = 
.029). Stress can contribute to a diminishment of self-concept (Pearlin et al., 1981). 
According to stress process theory, stress and its accompanying feelings of self- 
diminishment are counteracted by strengthening self-concept, through mastery and self-
esteem building. I will measure stress with Cohen’s Perceived Stress Scale (Cohen, 
Kamarck, & Mermelstein, 1983).  
 
2.2.2 Self-Efficacy 
According to Thoits (2010), “the impacts of stressors on health and wellbeing are 
reduced when persons have high levels of mastery, [and] self-esteem” (p. 41). Mastery 
and self-esteem building associated with stress reduction can be partially explained by the 
concept of self-efficacy. Albert Bandura, the pioneer in developing this concept, defines 
perceived self-efficacy as “people’s beliefs in their capabilities to produce given 
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attainments” (Bandura, 2006, p. 307). Bandura’s self-efficacy theory addresses perceived 
task capability through mastery experiences (Bandura, 2006). These accumulated mastery 
experiences can lead to transformational restructuring of efficacy beliefs, the belief that 
one can manage a stressful situation. Efficacy beliefs influence whether people think 
erratically or strategically, as well as optimistically or pessimistically. According to 
Bandura, perceived self-efficacy affects self-development and adaptation (Bandura et al., 
2003). Prior studies of older adults have shown that lower self-efficacy is associated with 
reduced physical function, and, in contrast, higher levels of self-efficacy correlate with 
lower rates of disability (Aggarwal et al., 2014; Femia, Zarit, & Johansson, 1997). 
Several studies have shown greater self-efficacy resulting in positive outcomes for older 
adults in varied areas, recovery from falls, fractures, and coronary surgery (Carroll, 1995; 
Fortinsky et al., 2002; Tinetti, Mendes de Leon, Doucette, & Baker, 1994). 
According to Tannenbaum (2008), psychological factors such as self-efficacy 
may also play an important role in explaining urinary incontinence and its control. While 
encouraging preliminary results of a small intervention trial (Kim, 2001) had shown 
increased self-efficacy in participants with stress urinary incontinence, the potential 
effects of interventions could only be accurately measured with a validated urinary 
incontinence questionnaire incorporating self-efficacy specifically for geriatric urinary 
incontinence. Tannenbaum and colleagues developed an evaluative instrument to assess 
self-efficacy for preventing or reducing urinary incontinence, the Geriatric Self-Efficacy 
Index for Urinary Incontinence (2008).  
I will measure self-efficacy with an adapted version of the Geriatric Self-Efficacy 
Index for Urinary Incontinence (GSE-UI). As I explored the self-efficacy scales, I found 
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the GSE-UI to be the best fit for my intervention. For the sake of simplicity and elegance 
in my research design, I added one question addressing self-efficacy in the intervention at 
hand, regarding the confidence of applying the elements of the intervention to manage 
urinary incontinence (see Section 4.12.12).  
 
2.3 Mindfulness-Based Stress Reduction 
Mindfulness-based stress reduction (MBSR) is a skill defined as “moment to 
moment awareness” (Grossman, Niemann, Schmidt, & Walach, 2004, p. 36), which is 
nonjudgmental and believed to promote wellbeing (Brown & Ryan, 2003). Mindfulness-
based stress reduction training was pioneered by Jon Kabat-Zinn in the late 1970s, and 
has shown long-lasting improvement of physical and mental health variables such as 
coronary artery disease and depression, a positive change in the attitudes and perceptions 
of participants with fibromyalgia and cancer, and reduced mood disturbances such as 
anxiety disorder and increased self-esteem (Grossman, 2004; Kabat-Zinn, 2003; Segal, 
Williams, & Teasdale, 2013). Mindfulness-based stress reduction has been applied to 
general populations of all ages as well as such diverse populations as medical school 
students and prisoners (Grossman, 2004; Moss, 2015; Samuelson, 2007). Mindfulness-
based stress reduction is taught as a series of eight 2-hour group sessions, with a full day 
retreat between weeks 6 and 7 (Kabat-Zinn, 2005). Participants learn both formal and 
informal ways to apply mindfulness to their daily lives. Mindfulness teaches participants 
to carefully attend to one thing at a time, and to notice thoughts and physical sensations 
without passing judgment (Kilpatrick et al., 2011). Practitioners learn to notice their 
environment and activities with a commitment to stay in the present moment. 
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Mindfulness training improves attention-related behavioral responses (Jha, Krompinger, 
& Baime, 2007). It has been shown to regulate visceral awareness and improve self-
regulation (Holzel et al., 2007). Mindfulness-based stress reduction has been proven a 
useful intervention for a “broad range of chronic disorders and problems” (Grossman, 
2004).  
A recent systematic review of MBSR conducted by Fjorback and colleagues 
(2011) showed impressive breadth of application across populations, such as medical 
students, women with fibromyalgia, community residents, recurrently depressed patients, 
and women with breast cancer. This systematic review also showed mindfulness-based 
stress reduction programs applied to a variety of conditions, such as anxiety, emotional 
distress, multiple sclerosis, rheumatoid arthritis, and COPD. MBSR showed 
demonstrable effects, with the review concluding that mindfulness-based stress reduction 
is recommended as “a useful method for improving mental health and reducing 
symptoms of stress, anxiety and depression, … and recommended in medical disease 
management to improve health-related quality of life” (Fjorback, Arendt, Ørnbøl, Fink, & 
Walach, 2011). 
 
2.3.1 Application of MBSR in Older Adults 
Mindfulness-based stress reduction has been used to treat a multitude of illnesses 
and conditions in older adults. The apparent connection between the mind and the body is 
germane to many biophysical processes (Chiesa & Serretti, 2010; Franco, 2011; Jha et 
al., 2007). Research has been done regarding the precise components of mindfulness that 
produce positive outcomes in community dwelling older adults (Gallegos et al., 2013). 
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Gallegos and colleagues (2013) studied the effects of specific MBSR activities, including 
yoga, sitting meditation, informal meditation, and body scanning on immune function, as 
measured by IL-6, on insulin-like growth factor concentrations, measured by IGF-1 
levels, and positive affect as measured by the Positive and Negative Affect Schedule 
(Watson, Clark, & Tellegen, 1988). Stronger immune function and more positive affect 
were both observed (Gallegos, 2013). 
In the older adult population, MBSR has already been successfully utilized to 
treat mood disturbances, loneliness, emotional distress, and improve executive function 
(Creswell et al., 2012; Lenze et al., 2014; Moynihan et al., 2013; Young & Baime, 2010). 
In a sample of older adults living in a continuing care retirement community, MBSR 
participants reported “significantly greater improvement in acceptance and psychological 
flexibility in role limitations due to physical health… [and] increased awareness, less 
judgment, and greater self-compassion” (Moss, 2015). Mindfulness-Based Stress 
Reduction has been studied in minority and low-income older adult populations (Szanton, 
Wenzel, Connolly, & Piferi, 2011). Szanton and colleagues (2011) conducted focus 
groups with African American women over 60 in low-income housing to understand 
“which parts of MBSR were most important…and whether they apply their training to 
daily challenges” (p. 1). They discovered that participants found MBSR particularly 
useful when undergoing medical procedures as well as dealing with depression and 
managing anger.  
Minfulness-Based Stress Reduction is a specific type of mindfulness meditation. 
More broadly, mindfulness has also been used to successfully treat chronic pain and other 
chronic conditions, including high blood pressure, in the older adult population, as well 
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as irritable bowel syndrome in the general population (Gaylord et al., 2009; Morone, 
Greco, & Weiner, 2008; Palta et al., 2012).  
Of particular interest, studies using mindfulness in persons with irritable bowel 
syndrome may suggest that IBS is a chronic condition quite similar to urge urinary 
incontinence in nature. While it has not been used in an older adult population, the 
success of a mindfulness intervention in IBS participants is particularly promising due to 
the similar results found when imaging the brain of patients with these disorders (Chang, 
2005; Garland et al., 2012; Gaylord et al., 2009). Functional neuroimaging studies reveal 
different regional brain activation responses, related to alterations in perception. 
Specifically, this exaggerated activation occurs in the emotional (anterior cingulated) 
cortex (Griffiths & Tadic, 2008). These differences occur in areas of the brain associated 
with attentional processes as well as response selection (Chang, 2005). Mindfulness 
enhances specific components of attention (Jha et al., 2007). Patients with irritable bowel 
syndrome and urge urinary incontinence both appear to catastrophize their experiences, 
and this heightened visceral sensitivity increases the likelihood of future episodes (Baker, 
2012; Chang, 2005). Catastrophizing is a cognitive distortion in which the person not 
only predicts a negative outcome but also assumes that if the negative outcome occurred 
it would be a disaster (Boyes, 2013).   
Coyne and colleagues (2009) report heightened sensitivity of bladder urgency, 
mood disturbances accompanying these perceptions, and high levels of “psychiatric 
morbidity” (p. 4) in individuals with urge urinary incontinence. Mindfulness may 
cultivate a nonreactive (a more calm, less reactive) mindset, which lowers the visceral 
sensitivity and thus also lowers the evaluation and judgment of threat in the situation 
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(Garland et al., 2012). Mindfulness may prove to be a fitting psychosocial intervention 
for urge urinary incontinence in older adult women; in fact, Baker and colleagues (2012) 
suggest MBSR may be “uniquely suited to treat the underlying psychological and 
physical symptoms associated with urge urinary incontinence” (p. 46). This study will be 
the first to compare the usefulness of MBSR versus the Health Enhancement Program, an 
active comparison condition, in older adult women.  
 
2.3.2 A Synthesis of Theories 
Stress process theory and the concept of self-efficacy contribute to an 
understanding of the mind–body relationship in urge urinary incontinence. One’s self-
beliefs, as theorized in the concept of self-efficacy, are linked to an individual’s 
management of stress. Mindfulness-based stress reduction, with its acquired skills of 
psychological self-regulation, may offer an opportunity for individuals with urge urinary 
incontinence to increase self-efficacy. Mindfulness-based stress reduction skills could 
facilitate cognitive-emotional self-regulation that increases self-efficacy, reduces the 
stress associated with UUI and its associated severity and bother.   
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We examined the research literature to evaluate evidence of mindfulness 
approaches to treat urge urinary incontinence in older adult women. Older adult women 
with urge urinary incontinence are not sufficiently treated with current practices, yet the 
potential application of mindfulness-based stress reduction to urge urinary incontinence 
is relatively unknown.  
A literature review was conducted to locate scientific literature using 
mindfulness to treat urinary incontinence in older adult women. No studies examined 
mindfulness for urinary incontinence specifically in an older adult female, or older 
adult, population. No mixed gender studies, nor studies only on men, with mindfulness 
as treatment of urinary incontinence were discovered. 
Two studies met the expanded inclusion criteria of mindfulness as a treatment 
for urinary incontinence in adults (not specifically older adults). Both demonstrated that 
mindfulness-based stress reduction reduced urge urinary incontinence symptoms and 
increased health-related quality of life and global impression of improvement after 
completion of the intervention and at follow-up. 
Mindfulness-based stress reduction remains a novel approach. Preliminary 
research indicates mindfulness-based stress reduction works in the general population to 
reduce urge urinary incontinence, but has not been examined in large clinical trials, or 





Urinary incontinence is a lower urinary tract syndrome defined as the inability to 
hold urine in the bladder because voluntary control is lost, resulting in involuntary 
leakage 3). Urge urinary incontinence disproportionately affects older women and 
adversely affects health related quality of life (Coyne, Sexton, et al., 2008; Nitti, 2001). 
Urge urinary incontinence (UUI) in older adult women is a distressing problem needing 
innovative solutions.  
 
3.3 Background 
Historically, urge urinary incontinence has been understood to be related to 
bladder dysfunction, poor muscle tone in the pelvic floor, obesity, nerve dysfunction, or 
a combination of these (Andersson, 2002; Fowler, Griffiths, & de Groat, 2008; 
Griffiths, Tadic, Schaefer, & Resnick, 2007; Subak et al., 2009). While these causes 
may explain some urge urinary incontinence, they do not account for all cases. In 
reality, most urge urinary incontinence is idiopathic (Qaseem et al., 2014). 
The decreasing efficacy of pharmacologic treatment and the tendency for 
women with urge urinary incontinence to require multicomponent behavioral therapy 
indicate a need for more effective treatment options (Hartmann et al., 2009; Tenfelde & 
Janusek, 2014). Recent research suggests that urge urinary incontinence may be due to 
abnormal function within the brain, rather than within the nervous system or bladder 
(Baker, Costa, Guarino, & Nygaard, 2014; Baker, Costa, & Nygaard, 2012). Women 
with urge urinary incontinence present with an autonomic nervous system imbalance 
while women with stress urinary incontinence retain autonomic nervous system balance 
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(Hubeaux et al., 2011; Im, Kim, Kim, & Choi, 2010). Tenfelde and Janusek discussed 
the possibility that meditative approaches may correct this autonomic nervous system 
imbalance in women with urge urinary incontinence (Tenfelde & Janusek, 2014). 
Preliminary research on mindfulness-based stress reduction (MBSR) to treat 
chronic conditions has been shown to regulate visceral awareness and improve self-
regulation (Tenfelde & Janusek, 2014). Mindfulness-based stress reduction has been 
proven a useful intervention for a “broad range of chronic disorders and problems” 
(Grossman, Niemann, Schmidt, & Walach, 2004). As such, it could be an intriguing 
integrative treatment for urge urinary incontinence, as urge urinary incontinence often 
proves refractory to common treatments (Hartmann et al., 2009). Older adult women 
with urge urinary incontinence are not sufficiently treated with current practices, yet 
little is known about the potential application of MBSR to UUI.  
 
3.4 Methods 
A literature review was conducted to determine if mindfulness-based stress 
reduction has been studied on the urge urinary incontinent older adult female 
population. The scope of this review included mindfulness interventions on older adult 
women with urinary incontinence. It was subsequently broadened to include all adults 







3.4.1 Search Strategy 
3.4.1.1 Databases  
The literature review was performed using the following electronic research 
databases: Academic Search Premier, AgeLine, Alternative Health Watch,  Biomedical 
Reference Collection, CINAHL, Embase, ERIC, Fuente Academica, Funk & Wagnall’s 
New World Encyclopedia, GreenFILE, Health Source: Consumer Edition, Health 
Source: Nursing/Academic Edition, Legal Collection, Library, Information Science & 
Technology Abstracts, MedicLatina, MEDLINE, Military & Government Collection, 
MLA Directory of Periodicals, MLA International Bibliography, Professional 
Development Collection, PsycARTICLES, Psychology and Behavioral Sciences 
Collection, PsychINFO®, PubMed, Regional Business News, Scopus, and 
TOPICsearch to locate relevant literature.  
 
3.4.1.2 Inclusion and Exclusion Criteria  
Inclusion criteria for this search were psychosocial/nonpharmacologic clinical 
trials and randomized controlled trials for older adults with urinary incontinence. 
Exclusion criteria were theory articles, studies that were diagnostic or addressing 
incidence and prevalence, opinion pieces, and articles that were not in English and had 
no translation available. Also excluded were studies with children as participants, 
studies with cancer patients or participants who were identified as cancer survivors, and 






An initial search using the keywords urinary incontinence, mindfulness, and 
older adults produced one result (Baker, Costa, Guarino, & Nygaard, 2014). Thus, 
search terms were significantly broadened to include the following phrases: urge 
urinary incontinence, urinary incontinence, incontinence, mindfulness-based stress 
reduction, mindfulness training, mindfulness intervention, psychosocial interventions, 
older adults, elderly, older adult women, older adult females, complementary 
therapy/ies, and alternative therapy/ies. Searches were systematically carried out within 
each database, using the same combination of terms in the same order. In certain 
databases, such as Scopus, it was necessary to add quotation marks around compound 
terms. Additional literature was located through a thorough search of the references 
within the articles identified, as well as through other sources.  
 
3.4.1.4 Search Results 
Ninety-one records were identified, 18 were duplicates, and 71 of the remaining 
73 were deemed irrelevant after a thorough review of the title and abstract (see Figure 
1). Studies on fecal incontinence; children; participants with, or who were survivors of, 
cancer; editorial views; theoretical articles; and articles in foreign languages were 
systematically excluded from review. No studies examined mindfulness as treatment for 
urinary incontinence specifically in an older adult female, or older adult, population. 
One explicitly stated at least one older adult woman was involved, while the other 
study’s oldest participant was 60 years old. Both of these studies limited recruitment to 
women only. No mixed gender studies, nor studies only on men, with mindfulness as 
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treatment of urinary incontinence were discovered in the literature review. Thus, two 
studies met the broadened inclusion criteria of mindfulness as a treatment for urinary 
incontinence in adults (not specifically older adult women).  
 
3.4.1.5 Grey Literature 
In addition to the systematic search of databases described above, a review of 
the grey literature was conducted. ProQuest Digital Dissertations was searched. The last 
4 years of conference proceedings from three organizations, representing each facet of 
the topic (complementary approaches, urge urinary incontinence, older adults) were also 
searched. The Academy of Integrative Health and Medicine’s 2014, 2015, and 2016 
conferences were searched and revealed no presentations about using mindfulness-
based stress reduction to treat urge urinary incontinence in older adult women. The 
Academy did not hold a 2013 conference. To be most inclusive, the search was 
broadened to mindfulness and urinary incontinence and this still yielded zero results. 
This was continued with the conference proceedings of the remaining two organizations 
chosen. 
The American Urogynecologic Society’s 2013, 2014, 2015, and 2016 
conference proceedings were searched and one presentation each year met the search 
criteria. The 2013 presentation, “Mindfulness-Based Stress Reduction (MBSR) vs Yoga 
on Urgency Incontinence: A Randomized Pilot Study” is a precursor to the Baker article 
discussed below (Baker, Costa, Guarino, & Nygaard, 2014). The 2014, 2015, and 2016 
conferences each had one presentation or participation in a Roundtable Discussion 
(alternately entitled Meet the Experts Educational Roundtables) by Baker, each entitled 
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“Mindfulness for Urinary Urge Incontinence.” Ms. Baker has not published related to 
this topic since 2014.  
The Gerontological Society of America’s 2013, 2014, 2015, and 2016 
conference proceedings were searched and no presentations met the criteria, even when 
broadened to simply mindfulness and urinary incontinence.  
 
3.5 Results 
Two studies met the broadened criteria of the literature review. Both studies 
using mindfulness-based stress reduction as a treatment for urge urinary incontinence 
saw significant reduction in the urinary incontinence episodes and overactive bladder 
symptoms of its participants after completion of an 8-week mindfulness-based stress 
reduction course, as well as increases in health related quality of life and global 
impression of improvement (Baker et al., 2014; Baker, Costa, & Nygaard, 2012).  
 
3.5.1 Synthesis of Literature 
Continued positive change, while equivocally statistically significant, was 
observed at 6-month and 1-year follow-ups. It is worth noting as a potential limitation 
that these studies were both conducted by research teams with almost identical 
members, and participants were recruited from the same community with the same 
recruitment strategies. The later study used yoga as the comparison condition, but 
technically it was not yoga, as emphasis was placed on physical movement and no 
education was given on breathing techniques or meditative methods. These are both 
traditionally an integrative part of yoga practice (Baker et al., 2014). Both studies were 
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published in the same journal, Female Pelvic and Reconstructive Surgery, which has an 
impact factor of 1.331.  
A summary of the study characteristics (participants, methods, interventions, 
follow-up, and results) and outcome measures (scales used, statistics, allocation, and the 
like) of both studies are found in Tables 1 and 2, respectively.  
 
3.5.2 Individual Article Summaries 
3.5.2.1 Mindfulness-Based Stress Reduction for Treatment of  
Urinary Urge Incontinence: A Pilot Study 
This pilot study by Baker, Costa, and Nygaard was the first study to examine 
mindfulness-based stress reduction as a treatment for urge urinary incontinence (Baker 
et al., 2012). This was a single-armed study, as is typical for a pilot study. Treatment 
response was measured with 3-day voiding diaries, the Overactive Bladder Symptoms 
and Quality of Life-Short Form, Health-Related Quality of Life, and Patient Global 
Impression of Improvement. Seven women were enrolled, a small sample size. 
However, researchers sought seven participants to meet a power of 80% and an alpha of 
0.05. The mean age was 54.9, with participants ranging in age from 43 to 60. The mean 
body mass index of participants was 28.4. This is noteworthy, since weight has been 
shown to affect urinary incontinence (Subak et al., 2009; Wing et al., 2010).  
Study findings were conclusive: After an 8-week mindfulness-based stress 
reduction intervention, incontinence episodes per day were reduced by 2.91 (p = .0005), 
a larger decrease than has been seen with cognitive behavioral therapy or 
pharmacologic treatment (Alhasso, McKinlay, Patrick, & Stewart, 2006; Hartmann et 
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al., 2009; Mannesse, Derkx, De Ridder, & van der Cammen, 2000). Significant 
improvements were also observed on the Overactive Bladder Symptoms and Quality of 
Life-Short Form, the Health-Related Quality of Life, and the Patient Global Impression 
of Improvement. At the 6-month follow-up, two women had sought additional 
treatment, but these significant results were sustained in the five remaining participants. 
At 1 year, one additional participant was lost to follow-up, but the significant results 
were sustained after 1 year in the remaining four participants. The authors note that the 
voiding diary may have added therapeutic value, and that the mindfulness-based stress 
reduction intervention is a labor-intensive treatment.   
 
3.5.2.2 Comparison of Mindfulness-Based Stress Reduction Versus Yoga  
on Urinary Urge Incontinence: A Randomized Pilot Study.  
With 6-Month and 1-Year Follow-up Visits 
This study by Baker, Costa, Guarino, and Nygaard is the first randomized study 
observing a mindfulness-based stress reduction intervention versus a comparison 
condition as treatment for urge urinary incontinence in adults (Baker et al., 2014). The 
study measured the percent change of urinary incontinence episodes between a 
mindfulness-based stress reduction (intervention) condition and a yoga (comparison) 
condition. The primary outcome was percent change in urinary incontinence leakage 
episodes, as recorded in the 3-day voiding diaries. Treatment response was also 
measured by percent change in the Overactive Bladder Symptoms and Quality of Life-
Short Form, the Health-Related Quality of Life scale, and the Patient Global Impression 
of Improvement. Twenty-four (13 MBSR, 11 yoga) of the original 30 (15 MBSR, 15 
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yoga) participants completed the majority of classes, 21 (12 MBSR, 9 yoga) completed 
the 6-month follow-up, and 20 (10 MBSR, 10 yoga) completed the 1-year follow-up. 
Researchers sought a range of 20–36 women to satisfy a two-tailed analysis with a 
power of 80% and an alpha of 0.05. A p value of <.05 was considered a statistically 
significant result. Block randomization was utilized to divide the participants into 
conditions. The participants were all community-dwelling women between the ages of 
22 and 79 (no mean age is provided), with urge-predominant urinary incontinence. Out 
of the 30 total participants, there were 9 women aged 65 and older enrolled in the study 
(J. Baker, personal communication, 2 November 2015). The comparison condition 
participated in a yoga program, structured after the Health Enhancement Program 
(HEP). HEP is designed to mimic the time and social engagement of the mindfulness-
based stress reduction classes (MacCoon et al., 2012). Each condition received a total of 
eight classes. It is important to note that neither condition received any bladder or 
behavioral education for urge urinary incontinence. The MBSR instructor had 
completed 14 days of professional training and an advanced teacher training intensive in 
mindfulness-based cognitive therapy (MBCT). The yoga courses mimicked the MBSR 
courses in class time and home practice of yoga.  
Findings indicated statistically significant drops in urinary incontinence leakage 
episodes at the 8-week and 6-month mark for those in the MBSR condition. At the 1-
year follow-up, episodes were further reduced in the MBSR condition compared to the 
yoga condition, but where differences were not statistically significant. Further, the 
MBSR participants scored higher on the Overactive Bladder Symptoms and Quality of 
Life-Short Form, the Health-Related Quality of Life scale, and the Patient Global 
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Impression of Improvement at all three time points (8-week, 6-month, and 1-year 
follow-ups) but results were only statistically significant at the 8-week mark.  
 
3.6 Discussion 
The women in these two studies (Baker, Costa, Guarino, & Nygaard, 2014; 
Baker, Costa, & Nygaard, 2012) may not represent the average woman with urge 
urinary incontinence since they responded to advertisements of the studies, and it was 
evident that the interventions would be complementary or integrative. Authors conclude 
that these results support larger-scale trials to evaluate mindfulness-based stress 
reduction. Additionally, these results also support trials in specific populations, such as 
older adult women.  
While mindfulness-based stress reduction has been applied in two pilot studies 
to treat urge urinary incontinence, no research has been done specifically in the older 
adult population. The two relevant studies both showed that mindfulness-based stress 
reduction was successful in reducing urge urinary incontinence severity (number of 
leakage episodes). The studies also showed that participants rated their overactive 
bladder symptoms lower, and their health related quality of life and global impression 
of improvement higher after completion of the intervention, and even at a later follow-
up time (Baker, Costa, Guarino, & Nygaard, 2014; Baker, Costa, & Nygaard, 2012).  
 
3.7 Conclusion 
The highest prevalence of urge urinary incontinence occurs in the population of 
older adult women (Markland, 2011). Given the underrepresentation of older women in 
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research studies, and the frequency of and distress associated with UUI, older women 
are a particularly important population to study (Devlin, 2010). Mindfulness-based 
stress reduction remains a novel approach within the scientific literature and research on 
its utility in older women with UUI is a pressing need. There is evidence that 
mindfulness-based stress reduction works in the general population to reduce urinary 
incontinence, but this has not been proven in large clinical trials, or in special 
populations like adults 65 and older. If MBSR proves effective in the urge urinary 
incontinent older adult female population, its implementation could impact quality of 
life and independence in affected women. It could also be an efficacious alternative to 
medications, whose side effects are disproportionately dangerous in the older adult 
female population (Franco, 2011; Mannesse et al., 2000). Benefits may extrapolate to 
the population at large, reducing not only personal but societal cost, and improving 









Table 1 Study Characteristics 
 Baker, J., Costa, D., Guarino, J. 
M., & Nygaard, I. (2014) 
Baker, J., Costa, D., & 
Nygaard, I. (2012) 
Participants n = 30 enrollees,  
      ≥ 18 years (22-79 years) 
White  
n = 24 completed intervention 
n = 7 enrollees 
Intervention Randomized MBSR or yoga Single-arm pilot study 
Follow-up n = 20 6-month follow-up visit 
n = 21 1-year follow-up visit 
1-year follow-up data 
Results Median percent change from 
baseline Overactive Bladder 
Symptom and Quality of Life 
Short Form and the Health-
Related Quality of Life greater 
at each time point for MBSR 
than for yoga; statistically 
significant only at 8 weeks (P = 
.003 and .02, respectively).  
At 8 weeks, 6/13 MBSR and 
0/11 yoga reported “very much 
better” or “much better” (p = 
.02) 
At 1 year, 6/12 MBSR and 1/9 
yoga reported “very much 
better” or “much better” (p = 
.16). 
UIEs/day decreased from 
4.14 at baseline to 1.23 after 
treatment (p = .0005) 
At study completion of 8-
week treatment, 5 of 7 
women were improved on the 
Patient Global Impression of 
Improvement, and 2 were 
unchanged. The PGI-I 
showed sustained or 
continued improvement 
Significant improvements on 
both Overactive Bladder 
Symptom and Quality of 
Life-Short Form Health-
Related Quality of Life were 
reported at study completion.  
PGI-I results were sustained 






Table 2 Outcome Measures 
 Baker, J., Costa, D., Guarino, 
J. M., & Nygaard, I. (2014) 
Baker, J., Costa, D., & 
Nygaard, I. (2012) 
 
  
Outcome measures Voiding diary 
OAB-q SF SQoL 
OAB-q SF HRQL 
PGI-I 
3-day bladder diary 
OAB-q SF SQoL 
OAB-q SF HRQL 
PGI-I 
Statistics Nonparametric analysis  
Both ITT and per protocol 
analysis were analyzed 
Parameters of power 80%, 
> = 0.05 (SD, 1.9), C = 1.5 
Both ITT and per protocol 
analysis were analyzed 
Allocation assignment Block randomization N/A 
p value p < .05 considered significant 
“no trends toward statistically 
significant differences in the 3 
different sessions of the 
groups about response to 
primary or secondary 
measurements” 
 
p = .0005 
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Symptoms of urinary leakage with urgency (known as urge urinary incontinence, 
or UUI) are common, disproportionately affect older women, and can be socially and 
psychologically devastating. Mindfulness-based stress reduction (MBSR) appears to be a 
favorable therapy for some women with UUI (Baker, Costa, Guarino, & Nygaard, 2014; 
Baker, Costa, & Nygaard, 2012). While men to a lesser extent do have UUI, the etiology 
of symptoms differs from that of women. For men, UUI is primarily due to bladder outlet 
obstruction due to an enlarged prostate, which would be unlikely to respond to MBSR. 
Therefore, this study is directed solely to women.  
 
4.1 Design Overview 
This research study explored the feasibility and preliminary efficacy of treating 
urge urinary incontinence (UUI) in older adult women with mindfulness-based stress 
reduction (MBSR) in comparison to the health enhancement program (HEP) through a 
randomized controlled pilot study. Feasibility determinants included both research 
feasibility (recruitment, retention, treatment fidelity) and intervention feasibility 
(acceptability, tolerability, treatment adherence). Clinical outcomes to evaluate 
preliminary intervention efficacy included severity of UUI symptoms, bother of UUI 
symptoms, perceived stress, and perceived level of self-efficacy of self-management of 
UUI symptoms. Preliminary efficacy of the intervention was also evaluated with the 
Patient Global Impression of Improvement (PGI-I), a process measure that rates the 
patient’s “response of a condition to a therapy” (Ryan, n.d., p. 1; Yalcin & Bump, 2003).  
This combined pilot feasibility study and randomized controlled trial (RCT) 
evaluated specific factors crucial to the success of a large trial to evaluate the effect of 
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MBSR on UUI in older adult women. Moore (2011) recommended that the pilot study 
design parallel the future larger study, particularly when evaluating feasibility in the pilot 
study. The capacity for hypothesis testing, or establishing causal inference is limited in a 
pilot study due to insufficient power; however, the information from efficacy testing is 
vital in informing future larger scale clinical trials (Leon, 2011). This study serves as a 
necessary step for the development of effectiveness trials of MBSR in treatment of UUI 
in older adult women by informing and guiding evaluation, implementation, and 
dissemination.  
 Aim 1: To determine the research feasibility of an RCT comparing MBSR 
and HEP in older adult women presenting with UUI, measured by 
recruitment, retention, and treatment fidelity. 
 Aim 2: To determine the intervention feasibility of an RCT comparing 
MBSR and HEP in older adult women presenting with UUI, measured by 
acceptability, tolerability, and treatment adherence. 
 Exploratory aim: To evaluate short term preliminary efficacy of MBSR for 
treatment of UUI in older adult women, in comparison to HEP, measured 
by symptom severity, symptom bother, perceived stress, perceived self-
efficacy, and the trajectory of change. 
 
4.2 Intervention Description 
The overarching goal of this research is to evaluate potential treatment options for 
older women with symptoms of UUI, with a specific focus on MBSR, a promising 
therapeutic approach in preliminary studies and one increasingly used to treat symptoms 
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associated with brain-visceral interactions (Grossman, Niemann, Schmidt, Walach, 2004; 
Kabat-Zinn, 2005). Feasibility and preliminary efficacy were tested in two randomized 
study arms: an MBSR intervention condition and an HEP intervention comparison 
condition. According to the literature, pilot studies are better poised to address their goals 
when study design incorporates comparison conditions (Leon, 2011). The comparison 
condition decision was made in concordance with the state of the science of the current 
intervention, as delineated in Section 4.12.1 (Nezu & Nezu, 2008). The reasoning is 
provided below in the Rationale for Selection of the Comparison Condition section. 
The interventionists in these two study conditions were certified and credentialed. 
Because of the sensitive nature of the condition, UUI, I elected to hire female 
interventionists for both treatment arms.  
 
4.2.1 Mindfulness-Based Stress Reduction (MBSR)  
Mindfulness-Based Stress Reduction is an 8-week psychosocial intervention 
delivered in a group setting. Participants attend nine total sessions, meeting for 2 hours 
each week for 8 weeks, with a retreat between weeks 6 and 7. Class instruction is 
augmented by daily home practice, consisting of listening to audio meditation recordings, 
practicing mindfulness skills, and completing weekly readings and self-reflection 
assignments. Homework (practice) is provided to each participant. This is the standard, 
protocolled MBSR, which I employed. Hence, the outcomes of this study can be 
compared with other biobehavioral studies of MBSR. The intervention was led by a 




4.2.2 Health Enhancement Program (HEP) Comparison Condition 
The Health Enhancement Program is also an 8-week psychosocial intervention 
delivered in a group setting (MacCoon, 2012). Identical to MBSR in its format, 
participants meet in nine sessions, 2 hours a week for 8 weeks, with a retreat between 
weeks 6 and 7. Class instruction is supplemented with weekly homework, much like the 
MBSR practice. Please see Section 4.12.2 for a comparison of the MBSR and HEP 
curricula. The Health Enhancement Program in itself is a detailed, clearly spelled-out 
intervention with each session’s content, homework, and interventionist’s interactions 
with the participants thoroughly delineated. The HEP protocol is a substantive active 
comparison condition, which delivers “skillful provision of common therapeutic 
elements” (MacCoon et al., 2012, p. 4) so as to not bias tests of intervention effects 
(Mohr et al., 2009). The HEP was taught by a certified health education specialist 
(CHES).  
 
4.2.3 Rationale for Selection of the Comparison Condition 
The HEP condition is responsive to the National Institutes of Health’s call to 
researchers to provide a comparison condition for MBSR studies that is of equivalent 
commitment and experience (Ospina et al., 2008). HEP has been previously validated for 
use as a comparison condition alongside an MBSR intervention and meets the following 
criteria: (1) class activities match MBSR activities as closely as possible; (2) these 
activities represent valid, active, therapeutic ingredients in their own right; and (3) these 
ingredients do not include mindfulness (MacCoon et al., 2012). The HEP is designed to 
match MBSR in 1) positive expectations of success by teacher and participant, 2) an 
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ongoing relationship between teacher and participant, 3) a conceptual framework 
supporting participant’s actions, and 4) specific actions and instructions for participant to 
follow (Kok et al., 2013).  
Using HEP as a comparison condition strengthened this RCT, as it is an active 
control condition for MBSR while remaining inert to mindfulness. It is credible to both 
participants and providers and offers a plausible alternative for success through 
therapeutic rationale.  
 
4.3 Participants 
Twenty-five postmenopausal females with UUI were recruited as participants into 
this study. My enrollment target range was 12-30 participants. I sought to enroll enough 
participants to obtain sufficient enrollment at completion, given typical attrition rates of 
15-20% (as high as 30% in one MBSR study) in the older adult population (Creswell et 
al., 2012; White et al., 2010).  
Interested women completed a brief screening over the phone. Screening 
confirmed the following eligibility and exclusion criteria: 
 
4.3.1 Eligibility Criteria 
The study enrolled older adult women with UUI. They could not be currently 
treating their UUI with medication, even hormone therapy, as this would have 
confounded results. Women who had attempted more extreme treatments and were still 
experiencing UUI were not considered as potential participants, as it would have been 
unlikely that MBSR would treat UUI that was refractory to that degree. Participants had 
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to be English speaking, as the interventions and homework were delivered in English. In 
summary, participants needed to: 
 Be postmenopausal, with an emphasis on older adult women, aged 65+.  
 Have urge predominant urinary incontinence, defined as score of > 3 
(moderate to severe urinary incontinence) on the Incontinence Severity Index 
(see Section 4.12.3) and predominant UUI as determined by question 3 on the 
3 Incontinence Questions (see Section 4.12.4; Brown et al., 2006). The 3 
Incontinence Questions (3IQ)  has been shown to be a quick and accurate way 
of diagnosing stress, urge, or mixed incontinence in most cases (Brown et al., 
2006; Holroyd-Leduc, Tannenbaum, Thorpe, & Straus, 2008; Rohr, 
Christensen, Ulstrup, & Kragstrup, 2004). 
 Have experienced urge urinary incontinence symptoms for at least 3 months. 
 Be committed to attend eight weekly sessions and one half day retreat 
between weeks 6 and 7. 
 Have no pharmacologic therapy for UUI within 3 weeks of enrollment and no 
plan to initiate such medications during the 8-week active treatment (eligible 
women who tapered off their medication to none by 3 weeks before the 
intervention began were included). 
 Plan to remain on hormone therapy or vaginal estrogen for the duration of the 
study if they were currently on it at enrollment; if not on it, have no plan to 
initiate. 
 Have had no previous intradetrusor Botox injection for UUI and no plan to 
receive it during the intervention. 
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 Have had no previous neurostimulation for UUI and no plan to receive it 
during the intervention. 
 Be English speaking. 
 
4.3.2 Exclusion Criteria 
The following exclusions were applied, as they could seriously limit participation 
or confound participant response to the intervention. Potential participants were asked to 
self-report on: 
 Predominantly stress, mixed, or other type of incontinence as determined by 
question 3 on the 3 Incontinence Questions (see Section 4.12.4). 
 Currently taking medications for Alzheimer’s disease or other dementias; 
these medications could interfere with their participation. 
 Known neurologic disease acknowledged to impact bladder function, 
including Parkinson’s disease, spinal cord injury, or stroke affecting urinary 
control; these diseases provide cause for UUI and as such the participant 
would be unlikely to benefit from the intervention. 
 Current symptomatic urinary tract infection that did not resolve prior to the 
start of intervention. 
 Current bladder infection that did not resolve prior to the start of intervention. 
 Use of an assistive device for ambulation (such as a cane, walker, or 
wheelchair) and feels that difficulties with bladder management are related to 
the slowed time in visiting the restroom (“Was UUI a problem before you 
began using the assistive device?”). 
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 Functionally incontinent, that is, having a mental or physical condition that 
prevents a person from visiting the restroom in time. 
 Ever diagnosed with interstitial cystitis. 
 Self-report of vaginal bulge protruding outside of the vagina.  
 Past participation in a formal program of MBSR.  
 Substantial, uncorrected hearing loss that would affect participation in a group 
setting (self-reported). 
 Substantial, uncorrected vision loss that would affect seeing projected slides 
or other class instruction (self-reported). 
 Limitations that preclude completing study questionnaires or surveys, such as 
difficulties with reading and writing. 
For this study, I did not exclude women based on medication use other than 
medications used to treat UUI. I assessed participants’ use of  antidepressant or anxiolytic 
medications, medications for sleep, pain management, and beta-blockers and whether or 
not their regimen was stable for 8 weeks before enrollment (Moynihan et al., 2013).  
Potential participants who declined or were excluded were referred to their uro-
gynecological caregiver if they inquired regarding treatment (Corsini-Munt, Bergeron, 
Rosen, Mayrand, & Delisle, 2014).  
In addition, I excluded women with a moderate to severe cognitive impairment, 
defined as a score of < 25 on the Montreal Cognitive Assessment (MoCA; Nasreddine, 
2010; Nasreddine et al., 2005), see Section 4.12.5, as the intensity and focus of the 
interventions necessitated that participants be cognitively engaged. Because this cannot 
be assessed over the phone during screening, it was assessed at the enrollment interview 
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as described in the Enhanced Enrollment section under Procedure below.  
 
4.3.3 Compensation 
I provided a total of $100 in gift card compensation to study participants. 
Participants who did not complete the study received a prorated amount of compensation. 
Compensation was staggered across the study for all participants, with $40 given after the 
retreat session between weeks 6 and 7 and the remaining $60 given at completion of 




Recruitment of older adults carries particular cautions; according to McHenry and 
colleagues (2015), it can be improved by cultivating relationships with community-based 
organizations, face-to-face contact with potential study participants, and providing 
service as an access point to eligible participants. According to Leon (2011), pilot sample 
size should be based on “the pragmatics of recruitment and the necessities for examining 
feasibility.”  
To minimize the risk of embarrassment from participating in the project, the study 
was advertised as a “Bladder health” and “Bladder management” study. Once the 
program began, it was scheduled and posted simply as “Mindfulness study” and “Health 
enhancement study” and did not refer to urinary incontinence.  
Participants were recruited from the University of Utah Health Sciences network, 
including the Pelvic Care & Incontinence Center, the Geriatrics Clinic, the Sleep-Wake 
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Center, and other germane health care provider units utilized by older adult women at the 
University of Utah Health Sciences Center (UUHSC) as well as other University of Utah 
Health Care clinics throughout the community. Fliers were posted in the School of 
Medicine, the College of Nursing, and the Health Sciences Education Building bulletin 
boards and women’s restrooms as well. Recruitment also included the Osher Lifelong 
Learning Institute on campus. The Osher Lifelong Learning Institute offers noncredit 
learning opportunities and engagement for adults 50 and older. They provided email 
blasts and I presented a “lunch and lecture” on urinary incontinence. Additionally, I gave 
a presentation at an Integrative Health and Resiliency conference on campus, which is 
attended by members of the community.  
Further, two databases within the University of Utah Health Sciences Center were 
used to recruit participants. The Center on Aging has a participant registry and the 
university has a Research Match division. Both were matched for age and gender and 
recruitment fliers were sent via email. Potential participants responded via return email, 
text, or phone call.  
Recruitment also included Salt Lake County senior centers, which necessitated an 
additional Institutional Review Board application, through the Utah State Department of 
Health and Human Services. Salt Lake County Aging and Adult Services has 19 senior 
centers and nine affordable senior living apartments under its purview. Salt Lake County 
Aging and Adult Services approved the IRB proposal to recruit at Salt Lake County 
senior centers. I recruited at these centers by posting fliers in the women’s restrooms and 
on their bulletin boards, and by giving short presentations regarding urinary incontinence 
to any interested center participants, and serving as a vendor at several senior center 
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health fairs, often in collaboration with the university’s Director of Research Participant 
Advocacy who represented Research Match. 
Further recruitment included fliers posted on bulletin boards in the community, 
provider referrals, and word of mouth recruitment. After gaining permission from the 
various managers, I posted fliers in grocery stores, pharmacies, coffee shops, recreational 
centers, libraries, and other community spots. The Utah Commission on Aging was 
helpful in providing networking connections to places of interest in the community. 
When allowed, I posted fliers inside stalls of the women’s restrooms. The exposure in the 
restrooms allowed for a private view of the study advertisement and the chance for the 
potential participant to remove the tear off portion without anyone else seeing them do 
so. I also presented at a booth at a regional KUTV Health Fair held in a local convention 




Participant screening occurred on the phone with interested respondents. When 
potential participants called, I explained the basic framework of the study, the general 
time commitment, the transportation options, and the remuneration. For the purposes of 
transparency and reproducibility, a screening script was followed (see Section 4.12.6). 
When the participant expressed interest, the eligibility and exclusion criteria were 
reviewed, one at a time. When a potential participant qualified for the study, she was 
invited to come in for an enrollment interview.  
This enrollment interview took place in the same location as the intervention 
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classes to facilitate participant comfort in the logistics of location and parking. I sent a 
map and instructions for navigation and parking via email or postal service mail, and I 
met the participant at the parking garage. I then escorted them to the building where the 
enrollment interview, and eventually the course itself, took place. This enhanced 
enrollment procedure allowed participants an advance orientation to the study site, 
increasing the participant’s ease and facilitating retention (McHenry, 2015).  
 
4.5.2 Informed Consent 
At the interview, potential participants who met the eligibility criteria were 
provided with an informed consent document. The consent document, along with all 
study information, was written with 14 font size or greater, in serif font, in black type on 
matte, white paper, and double spaced, to accommodate this population (Kicklighter, 
1991; National Institute on Aging, 2008). The language used in both oral and written 
communication throughout the entire study process was as nontechnical as possible (U.S. 
Department of Health and Human Services, 1996). After giving the participant ample 
time to read the document and ask questions, I reviewed the consent document with 
participants paragraph by paragraph. Thus, participants were informed of the 
confidentiality guidelines of participation and given a signed copy of the consent 
document to take home.  
 
4.5.3 Enhanced Enrollment 
Upon completion of the informed consent document, I administered the MoCA 
and, as appropriate, proceeded with administration of the baseline measures. Only one 
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interviewee failed the MoCA. In this case, it was explained that the study had a cutoff for 
cognitive function, and the interviewee scored below it. The participant was already 
aware of their cognitive impairment, having been previously diagnosed with dyslexia. I 
informed enrolled participants of their assigned intervention while preserving the 
blinded-to-condition nature of the study design.  
Each potential participant who came for the enrollment interview, with the 
exception of the potential participant with dyslexia, signed the consent document and 
enrolled in the study. In addition to a signed copy of the consent document, participants 
were also given a study summary highlighting the key features and my contact 
information in a clear, bulleted one-page document. Because this was an intervention 
delivered to a group of participants, a set of guidelines to encourage respect of 
confidentiality was also shared with each enrolled participant (see Section 4.12.7).   
 
4.5.4 Randomization  
As outlined in the Consolidated Standards of Reporting Trials (CONSORT) 
(Chan et al., 2013; Schulz, Altman, Moher, & Group, 2010), participants were assigned 
to their respective intervention condition through a process based on chance, which is 
random and cannot be predicted, to avoid selection bias or potentially biased outcomes. 
Participants were randomized into the MBSR or HEP condition according to the order of 
enrollment, and randomization was generated through the block method. The block 
method was utilized to ensure that enrollment was generated with a 1:1 ratio. Using 
blocking can increase predictability, so CONSORT recommends blinding the 
interventions and/or varying the block sizes to retain unpredictability (Chan et al., 2013; 
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Schulz et al., 2010). I applied these measures of allocation concealment. I varied the 
block sizes and placed the randomized condition selection into an envelope, marked with 
an interview number. I did not refer to the randomized result prior to the interview. 
Participants were blinded to the study condition. This adherence to CONSORT guidelines 
potentially diminishes dropout rates in the comparison condition (Chan et al., 2013; 
Schulz et al., 2010). Prior studies regarding methodology have provided support for such 
safeguards (Pildal et al., 2007; Wood et al., 2008). All study protocols, recruitment 
procedures, measures, and instruments were reviewed and approved by the University of 
Utah Institutional Review Board and the Department of Human Services Review Board 
prior to recruitment (UU IRB #00095461; DHS IRB #0589).  
 
4.5.5 Data Management  
Data management followed regulations for protection of human participants as 
well as confidentiality. The main risks for this study were breach of confidentiality and 
elevated distress. This was acknowledged in the informed consent document. Participants 
were informed of expectations of privacy and confidentiality. Good clinical practices 
were strictly adhered to in the study, from planning stages through completion 
(International Conference on Harmonisation of Technical Requirements for Registration 
of Pharmaceuticals for Human Use, 1996; World Health, 2005). Good clinical practices 
encompassed research staff training, informed consent procedures, Institutional Review 
Board (IRB) reporting, and monitoring/oversight procedures of both interventionists and 
participants (Leon, Davis, & Kraemer, 2011). These four items were documented and 
reviewed. Interventionists and research staff were and are CITI certified. Consent 
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procedure followed IRB protocol. IRB reporting was done through the University of Utah 
IRB and the Department of Human Services IRB. I oversaw participant monitoring 
during the recruitment, consent, randomization, and evaluation phases and 
interventionists and participants during the intervention phase. I tracked study progress 
including screening, demographic and clinical data, consenting, intervention, and 
evaluation. I was also responsible for data management, including data entry, accuracy, 
and integrity. All attempts to safeguard confidentiality were made using technological 
and physical precautions. Every effort was and continues to be taken to preserve the 
participants’ dignity, respect, and autonomy.  
Participants were assigned a study identification number to maintain a 
confidential environment. Data are electronically managed in Research Electronic Data 
Capture (REDCapTM) hosted at the University of Utah. REDCapTM is a secure, web-
based application intended to support data capture for research studies. REDCapTM 
provides 1) an intuitive interface for validated data entry, 2) audit trails for tracking data 
manipulation and export procedures, 3) automated export procedures for downloads to 
common statistical packages, and 4) procedures for importing data from external sources. 
Data were exported to IBM SPSS version 24.0 (IMB Corp, 2016) for data 
analysis. All research records are kept private per the IRB policy and procedures at the 
University of Utah. Records are kept in locked filing cabinets and entered into encrypted 
computers protected with passwords. A separate file linking study identification numbers 
with contact information is maintained. All files are kept in secure databases and secure 
locked filing cabinets behind locked doors at the University of Utah.  
Both the CONSORT (Chan et al., 2013; Schulz et al., 2010) and Standard 
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Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines (Chan et 
al., 2013) were followed. 
 
4.6 Setting 
Both intervention groups were held in comfortable, small classrooms at the 
University of Utah College of Nursing in the late afternoon to avoid conflicts with 
academic classes. Screens were placed outside the classroom door to provide privacy to 
participants.  
 
4.7 Measures  
4.7.1 Demographics  
Participants’ age, race, ethnicity, BMI, caffeine intake, and medication use were 
recorded at the enrollment interview after participant consent was obtained. The 
demographics questionnaire is included in Section 4.12.8. Demographic collection at 
baseline also included date of birth, marital status, race/ethnicity, education, brief 
gynecologic and medical history, brief UUI history, previous treatment for UUI, weight, 
height, medication use, life satisfaction, and life stress. Caffeine use and medication were 
recorded again at completion of study, to determine whether or not use remained constant 
throughout the study.   
 
4.7.2 Feasibility Measures 
The feasibility measures are divided into research feasibility measures, having to 
do with the research process, and intervention feasibility measures, having to do with the 
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participant process and outcome. See Section 4.12.9 for scheduled administration of 
measures.  
 
4.7.2.1 Research Feasibility Measures 
The rationale for my selected research feasibility measures, which are defined 
individually below, is drawn from the recommendations of Lancaster, Dodd, and 
Williamson; Leon, Davis, and Kraemer; Thabane et al.; Nezu and Nezu; and others 
(Lancaster, Dodd, & Williamson, 2004; Leon, Davis, & Kraemer, 2011; Nezu & Nezu, 
2008; Thabane et al., 2010; Tickle-Degnen, 2013). These researchers recommended 
incorporating the following measures in pilot studies to evaluate the capacity of the 
research team to properly and successfully conduct a larger study.  
Consent rate is an important determinant for feasibility studies, as these studies 
are typically conducted in preparation for a larger scale trial (Lancaster et al., 2004).  
Treatment fidelity measures how closely an intervention is delivered in 
comparison to how it was drafted and designed (Hildebrand et al., 2012). Hildebrand and 
colleagues (2012) explain that the absence of demonstrated treatment fidelity threatens 
internal and external validity of observed outcomes. Treatment fidelity was evaluated in 
both interventions through five recognized standard of science elements: study design, 
provider training, treatment delivery, treatment receipt, and enactment of treatment skills 
(Bellg et al., 2004).  
To ensure treatment fidelity in study design, the treatment dose was applied 
evenly to all participants, within and across conditions. To minimize contamination 
across treatment and comparison conditions, the two interventions’ meetings were 
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conducted on separate days, so interventionists and participants from each condition did 
not ever interact with the other condition. Participants were blinded to condition. 
Interventionists and participants from both conditions never met or interacted with one 
another, avoiding confounding the study.  
To ensure treatment fidelity in provider training, I confirmed that interventionists 
met a priori performance criteria and operated from their respective standardized 
manuals. I also ensured that interventionists delivered their separate interventions in 
similar ways, with standardized materials, length of class, and assessments. I documented 
their respective certification and credentials. 
Treatment delivery refers to the adherence of the interventionists to the 
intervention protocols. Since the weekly interventions were not recorded, and since 
interventionists may overestimate the content addressed, it is valuable to measure 
treatment delivery from both the interventionist and participant perspective. To ensure 
treatment fidelity in treatment delivery, I met with each interventionist after each session 
and asked them to verify what they delivered and compared it with what was planned. 
Additionally, I administered brief treatment delivery checklists to participants at the 
completion of the intervention, asking participants to mark the items that were taught 
throughout the course of the intervention. Since there was no video or audio recording of 
the weekly interventions, treatment delivery was measured both from the interventionists’ 
and the participants’ perceptions to triangulate the data. I also confirmed the availability 
of substitute interventionists for each condition should the primary interventionist be 
unable to lead a session. This occurred once for each interventionist and course. A 
certified substitute was obtained and participants expressed comfort with and confidence 
81 
 
in the substitute.  
To ensure treatment fidelity in treatment receipt, I confirmed with the 
interventionists that participants understood the information provided in the intervention. 
This was evaluated by having the interventionists ask questions and discuss materials 
with participants and collect self-monitoring/self-reporting data. Participants proved 
eager to have these discussions weekly in class as well as outside of class with the 
instructor who made themselves available. 
To ensure treatment fidelity in enactment of treatment skills, I verified that 
interventionists have processes in place that allow them to “monitor and improve the 
ability of [participants] to perform treatment-related behavioral skills” (Bellg et al., 2004, 
p. 448). These processes included monitoring and giving feedback on practice sessions, 
as well as collecting homework data and logs.  
 
4.7.2.1.1 Recruitment  
Recruitment was measured as number of people enrolled (Thabane et al., 2010). I 
determined referral source (Wesson et al., 2013). I measured the ratio of contacted to 
enrolled and recorded reasons for exclusion (by researcher) or declining (by respondent).   
 
4.7.2.1.2 Retention  
Retention was measured as percent of enrolled participants completing the study 
and accounted for reasons for attrition (Leon et al., 2006). If a participant did not attend a 
session, a courteous follow-up telephone call was placed, exploring what the attendance 
challenge may have been. These data were recorded in field notes and the information 
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was handled as protected data.  
 
4.7.2.1.3 Treatment Fidelity  
Treatment fidelity was measured by documenting how study design, provider 
training, treatment receipt, and enactment of treatment skills were addressed throughout 
the study. Treatment delivery was measured by consulting with the interventionists after 
each session, noting what they were scheduled to do and asking them to relate what they 
did. We met directly after each week’s intervention to confirm that treatment integrity 
objectives were met. A 75% or higher achievement on these objectives was considered 
the standard confirming objectives being met (Nezu & Nezu, 2008). Treatment delivery 
was also measured by a checklist given to participants at study completion, to mark those 
concepts covered in the weekly interventions. A 75% or higher achievement on these 
participants’ reports is typically the standard to confirm the interventionists’ concordance 
with their respective intervention protocols (Nezu & Nezu, 2008).  
 
4.7.2.2 Intervention Feasibility Measures  
The rationale for my selected intervention feasibility measures, listed individually 
below, is also drawn from the scientific literature regarding feasibility studies (Arain, 
Campbell, Cooper, & Lancaster, 2010; Bowen et al., 2009; Lancaster et al., 2004; Morin, 
2013; Sturdy et al., 2003). Lancaster (2004) and colleagues recommend determining 






Acceptability was measured as a positive versus negative response to the 
question, “How did it go today?” Following each session, two randomly selected 
participants in each intervention were approached by me and assessed on this 
acceptability question. The aggregate data were analyzed. 
 
4.7.2.2.2 Tolerability 
Tolerability was measured as number of dropouts due to stated distress from or 
dislike of either intervention experience, as opposed to someone needing to withdraw due 
to a family emergency or illness. (Moore, 2011; Sturdy, 2013). Participants who 
withdrew were asked to respond to a single question, “Help me understand what made 
this challenging?”  
 
4.7.2.2.3 Treatment Adherence  
Treatment adherence was measured by attendance and homework completion at 
each session, as recorded by the interventionists. Attendance was tracked as excused 
versus unexcused. Participants submitted each week’s homework to evidence homework 
completion and this was tallied and recorded (measured as turned in/not turned in).  
 
4.7.2.3 Preliminary Efficacy Measures 
The four measures of preliminary efficacy, the Incontinence Severity Index (ISI), 
the Overactive Bladder Questionnaire Short Form (OAB-q SF), the Perceived Stress 
Scale (PSS), and the Geriatric Self-Efficacy Index for Urinary Incontinence (GSE-UI), 
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were administered at baseline and again at study completion. Immediately following the 
final intervention session, participants received study instruments to be filled out and 
collected. Participants received their final gift cards at this time. These measures needed 
to be ≥ 75% completed to be included in data analysis. They were collected from all 
enrollees, even those who dropped out of the classes, with the exception of one who 
moved out of state under duress and left no contact information.  
 
4.7.2.3.1 Incontinence Severity Index (ISI) 2-Item Scale  
The Incontinence Severity Index (Sandvik, Espuna, & Hunskaar, 2006; Sandvik, 
Seim, Vanvik, & Hunskaar, 2000) is a short, simple, and sensitive measure of urinary 
incontinence in women. Sandvik and colleagues (2006) reported that the ISI 
demonstrated “good criterion validity and good construct validity” (p. 520). Pereira and 
colleagues reported satisfactory survey validity (Pereira, Santos, Correia, & Driusso, 
2011). Murphy and colleagues reported strong convergent validity of the ISI as well 
(Black, Griffiths, & Pope, 1996; Murphy et al., 2006). While no English research article 
reports a Cronbach’s alpha (α) reliability value for the ISI, the earlier cited Portuguese 
study by Pereira and colleagues reported that Cronbach’s α coefficient = 0.93, evidencing 
“excellent reliability and consistency of the [ISI] instrument” (Pereira et al., 2011). 
Pereira and colleagues (2011) also reported intraclass correlation coefficient and standard 
errors of measurement at 0.96 and 0.43. The Pearson correlation between the ISI and pad 
test revealed a strong positive one (r = 0.72, p <.0001; Pereira et al., 2011).  
Categories of ISI are divided into None (0), Slight (1-2), Moderate (3-6), Severe 
(8-9), and Very Severe (12). The ISI was administered at baseline and at study 
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completion. See Section 4.12.3. Adequate completion of the ISI: completion of two items 
and only one possible response checked for each question.  
 
4.7.2.3.2 Overactive Bladder Questionnaire Short Form (OAB-q SF),  
19-Item Scale  
The Overactive Bladder Questionnaire Short Form (K. S. Coyne, Thompson, Lai, 
& Sexton, 2015) measures symptom bother on a Likert-type scale from 1 (not at all) to 6 
(a very great deal). The OAB-q is a “reliable and valid instrument” (K. Coyne et al., 
2002, p. 563), able to differentiate between participants with and without overactive 
bladder incontinence (K. S. Coyne et al., 2015). K. Coyne and colleagues (2002) reported 
Cronbach α values ranging from 0.86 to 0.94. The OAB-q shows that overactive bladder 
symptoms cause substantial symptom bother and “have a negative impact on HRQL” (K. 
Coyne et al., 2002). While the OAB is validated as a single 19-point scale (PRO4Pfizer 
representative Sheryl, personal communication, August 26, 2016) to measure bother, it 
can also be viewed within its two parts. Part 1 (Q1-6) addresses severity and Part 2 (Q1-
13), often called HRQL, addresses bother. K.S. Coyne (2015) and colleagues 
demonstrated that the OAB-q SF has “good convergent validity, discriminant validity, 
internal reliability, and reproducibility” (K.S. Coyne et al., 2015, p. 255). The OAB-q SF 
was administered at baseline and at study completion. See Section 4.12.10.  
Adequate completion of the OAB-q SF: completion of at least 15 items, with only 





4.7.2.3.3 Perceived Stress Scale (PSS-10), 10-Item Scale  
The Perceived Stress Scale (Cohen, Kamarck, & Mermelstein, 1983; Cohen, 
Kessler, Underwood Gordon, 1995; Cohen & Williamson, 1988) measures stress in the 
last month on a Likert-type scale from 0 (never) to 4 (very often). Scores range from 0 to 
40; higher scores relate to higher levels of perceived stress. Notably for this study, it has 
been shown to correlate with physical symptomatology (Cohen & Williamson, 1988; 
Gallegos, Lytle, Moynihan, & Talbot, 2015). Cohen and colleagues (1983) state that the 
PSS demonstrates “substantial reliability and validity” (Cohen et al., p. 394) and 
presented coefficient α reliability at 0.84, 0.85, 0.86 in three separate samples; notably for 
application in the current study, the authors found “age was unrelated to PSS” (Cohen et 
al., 1983, p. 390) and there were no differences between males and females. The PSS has 
four questions that are reverse scored, and this was employed during data analysis. The 
PSS-10 was administered at baseline and at study completion. See Section 4.12.11.  
Adequate completion of the PSS-10: completion of at least 8 of 10 items, with 
only one of 4 possible response items checked for at least 8 questions. This is an 80% 
completion rate.  
 
4.7.2.3.4 Geriatric Self-Efficacy Index for Urinary Incontinence (GSE-UI),  
13-Item Scale, Adapted 
The GSE-UI measures self-efficacy with regard to urinary incontinence in older 
adults. The index is significantly correlated with “symptom severity and impact on 
everyday life” (Tannenbaum, 2008, p. 544). As I measured severity and bother as two 
distinct outcome measures, this correlation is a noteworthy one. The GSE-UI has a 
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sensitivity of 0.75 and a specificity of 0.78 (Tannenbaum et al., 2008; Tannenbaum et al., 
2009). Tannenbaum reported Cronbach’s α = 0.90 (Tannenbaum et al., 2009). To 
measure participant self-efficacy regarding the skillset participants gained in their 
respective interventions, I included one self-efficacy question using Bandura’s guidelines 
(Bandura, 2006): “How confident are you that you can implement the elements of what 
you learned to manage your urine control?” Thus, the GSE-UI scale as adapted for this 
study has 13 questions. Scores range from 0 to 130, and responses are recorded on a 
Likert-type scale from 0 (not confident) to 10 (very confident). The adapted GSE-UI was 
administered at baseline and at study completion (see Section 4.12.12). Adequate 
completion of the adapted GSE-UI consisted of completion of at least 10 of 13 items, 
with only 1 of 10 possible response items circled for each of those 10 questions. This is a 
77% completion rate. 
 
4.7.2.4 Process Measure  
4.7.2.4.1 Patient Global Impression of Improvement (PGI-I), 1-Item Scale  
As this feasibility study is to inform the potential for a future, larger scale trial, it 
is important to note at what stage of the treatment any changes, whether positive or 
negative, occur. A Patient Global Impression of Improvement measure was used in both 
conditions throughout the intervention phase to assess the process of change. Each 
participant filled out a Patient Global Impression of Improvement after each session, 
measuring their own responsiveness to the intervention. While this added a slight amount 
of participant burden, it allowed me to see if and when effects were seen. The PGI-I has 
“established construct validity” (Yalcin & Bump, 2003, p. 98) for treatment response in 
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reference to incontinence. Srikrishna, Robinson, and Cardozo (2010) noted that the PGI-I 
has been validated specifically in incontinence and that it shows “excellent test-retest 
reliability” (Yalcin, 2003, p. 523). The PGI-I was administered after each study session, 
for a total of nine times (8 weeks plus retreat between weeks 6 and 7). See Section 
4.12.13. Adequate completion: one item answered with one choice selected.  
 
4.8 Analytic Plan 
There are five components to my analytic plan: analysis of demographics, 
research feasibility measures, intervention feasibility measures, outcome measures, and 
process measures. After completion of all data collection, data were entered into 
REDCapTM. Since data entry was completed by one person, it was checked by a second 
member of the research staff, Daniela McCroby. Discrepancies were noted by the second 
team member and I checked the original participant paper form and entered the corrected 
data into REDCapTM. Data were exported to IBM SPSS version 24.0 for all analyses 
(IBM Corp., 2016).  
I conducted preanalysis of data, running frequency statistics for missing data and 
outliers. If not attended to, missing data and outliers could affect my assumptions for 
normal distribution. Categorical variables were checked by noting minimum and 
maximum values, noting valid and missing cases, and finding out where any errors occur. 
Continuous variables were also checked by noting minimum and maximum variables, 
noting the mean score, and then considering if these values seem sensible or if something 
appears out of range. The SPSS function, Summarize Cases, was also helpful to the data 
cleaning process. As explained by Van den Broeck and colleagues (2005), after 
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identification of errors, three options are available to the researcher: correcting, deleting, 
or leaving the error unchanged. Data cleaning is a study-specific process to some degree, 
but I followed the general guidelines as recommended by Van den Broeck et al. (2005). 
When missing data needed to be imputed within the Patient Global Impression of 
Improvement, I assumed that the previous measure stands. 
I conducted preanalysis of my demographic variables to evaluate if the sample 
within each treatment arm were similar. Gender was not compared between conditions, as 
I recruited women only. I utilized chi square tests on the categorical demographic 
variables (race and ethnicity) and independent t tests on the continuous variables: age, 
BMI, Incontinence Severity Index score, Montreal Cognitive Assessment (MoCA) score, 
medication use, and caffeine use, to evaluate whether the MBSR and HEP conditions 
were comparable. When my distributions for variables did not achieve normality, I was 
unable to use independent t tests and instead used Mann-Whitney U tests, the 
nonparametric version of independent t tests.  
Analysis of research feasibility measures, intervention feasibility measures, 
outcome measures, and the process measure is addressed in response to each study aim 
described below. Section 4.12.9 provides an overview of these measures.  
 
4.8.1 Aim 1  
Aim 1 was to determine the research feasibility of MBSR and HEP 
implementation in older adult women presenting with UUI. Research feasibility 
determinants include recruitment, retention, and treatment fidelity.  
Data analysis for the recruitment and retention portions of this aim were 
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performed through descriptive statistics, displayed in a CONSORT flowchart illustrating 
the number of participants who were screened, met eligibility/exclusion criteria, enrolled, 
consented, participated, and completed the study. Data addressing reasons why potential 
participants were ineligible, why participants were not consented (exclusion and 
declining), and reasons for participant attrition were described in this flowchart. See 
Figure 2, Section 4.12.14. 
To complete my understanding of research feasibility, I inquired of potential 
participants how they became aware of the study and noted these in my REDCap data.  
Treatment fidelity consists of study design, provider training, treatment delivery, 
treatment receipt, and enactment of treatment skills. Study design, provider training, 
treatment receipt, and enactment of treatment skills were documented to evidence 
accomplishment as described earlier. Treatment delivery was measured by two data 
sources: 1) through conversations after each intervention session with respective 
interventionists verifying that they addressed the content they were scheduled to address, 
and 2) a checklist administered to participants at study completion, to determine if 
content was delivered per protocol. Treatment delivery is considered adequate if the 
interventionists’ observance level equals 75% of scheduled content to be delivered, as 
evidenced through two data measures: 1) interventionists’ verification of the individual 
session objectives in meetings with me following each session, and 2) participants’ 






4.8.2 Aim 2  
To determine the intervention feasibility of MBSR implementation in older adult 
women presenting with UUI, in comparison to HEP implementation. Intervention 
feasibility determinants include acceptability, tolerability, and treatment adherence.  
Data analysis was completed to evaluate the intervention feasibility determinants. 
Acceptability was recorded as participant feedback documented after each session. Two 
participants were randomly selected after each class and asked the question, “How did it 
go today?” Participant answers were coded as positive or negative expression and 
described as a percentage. Qualitative analysis of these data is beyond the scope of this 
dissertation; as such, those data will be described in written form in the respective results 
and discussion sections of subsequent manuscripts reporting on the study.  
Tolerability is directly related to attrition and was measured as drop-out count and 
reported as a percentage. I inquired of those who left the study early why the intervention 
was challenging. Brief qualitative data were available in this regard, and as the sample 
size is quite small for those who left the study, I reported this information qualitatively. 
Treatment adherence was measured in two ways. First, treatment adherence was 
measured as attendance and reported as a percentage. Homework completion was also 
measured and reported in percentages.  
These three intervention feasibility outcomes are compared against available 
standard intervention feasibility measures of success (Bellg, 2004; White, 2010). 
However, it is critical to note that this is a pilot study—with an as yet unevaluated 
population—so part of my evaluation was to discern barriers to and facilitators of 
intervention feasibility.  
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4.8.3 Exploratory Aim  
To evaluate short-term preliminary efficacy of MBSR for treatment of UUI in 
older adult women, in comparison to HEP implementation, including symptom severity, 
symptom bother, perceived stress, perceived self-efficacy, and rate and trajectory of 
change.  
Analysis of preliminary efficacy as stated in the exploratory aim was addressed in 
response to the set of research questions (RQ 1-4) examining the outcome measures 
(Incontinence Severity Index [ISI], the Overactive Bladder Questionnaire Short Form 
[OAB-q SF], the Perceived Stress Scale [PSS], the adapted Geriatric Self-Efficacy Index 
for Urinary Incontinence [GSE-UI]) and the research question (RQ 5) examining the 
process measure (Patient Global Impression of Improvement [PGI-I]).  
 RQ 1: Does MBSR reduce UUI severity in older adult women as compared to 
HEP?  
Severity was analyzed by the ISI and informally through the OABq-SF Part 1 
scores. 
 RQ 2: Does MBSR reduce UUI bother in older adult women as compared to 
HEP?   
Bother was analyzed by the overall and Part 2 (HRQL) scores of the OAB-q SF.  
 RQ 3: Does MBSR reduce older adult women’s perceived stress in older adult 
women as compared to HEP?  
Perceived stress was analyzed by the PSS scores.  
 RQ 4: Does MBSR increase older adult women’s self-efficacy surrounding 
self-management of UUI symptoms as compared to HEP?  
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Perceived self-efficacy was analyzed by the adapted GSE-UI.  
Each research question above was analyzed using independent samples t tests or 
Mann Whitney U tests (the nonparametric alternative to independent samples t tests. I 
analyzed the impact of the independent variable treatment condition on each dependent 
variable with several assumptions as put forth by Green and Salkind (2008) as well as 
Munro (2005).  
1) The distribution of the dependent variable is normal. I checked this by running 
frequency statistics and visually evaluating the results in a histogram. 
According to Green and Salkind (2008) the independent t test may “yield 
reasonably accurate p values even when the normality assumption is violated” 
(p. 176). They state that a sample size of 15 may allow this accurate yield.  
2) The independent variable (MBSR or HEP) is categorical (nominal in this 
case), and the dependent variable is continuous (ISI, OAB-q SF, PSS, and 
GSE-UI). 
3) The groups are mutually exclusive, meaning each participant can only 
contribute a score to one condition and not the other.   
4) The variance of the individual outcome variable of the two groups is similar. I 
discover this in my demographics frequencies described above. This is the 
“requirement of homogeneity of variance” (Munro, 2005, p. 140).   
According to Green and Salkind (2008) and Pallant (2013), the assumptions of the 
Mann-Whitney U test are less stringent than the parametric technique but include the 
following: 
1) The continuous distributions for the test variable are the same (except their 
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medians) for the two populations. 
2) The cases represent random samples from the two populations.  
3) The scores on the test variable are independent of each other. 
4) The z-approximation test requires a sample size of more than 30. It is worthy 
to note that the z-approximation test does not have to be used—SPSS will 
print an exact test if the number of cases is less than or equal to 30. This is the 
situation this study fits into, as total participants numbered 25.  
If the assumptions for the independent t tests hold, I determine if there are 
significant differences between the outcome measures. I set the value of p < .05 as the 
standard for significant differences. 
When I used the Mann-Whitney U test to interpret the outcome, I indicated the 
direction of the difference.   
While the Mann Whitney U tests showed between condition differences, the 
within condition differences were addressed by the use of paired t tests. When paired t 
tests could not be used, the Wilcoxon signed-rank test was used to compare the within 
condition differences, that is, change from baseline to completion within the same 
condition (Pett, 2015).  
 RQ 5: What is the rate and trajectory of change, as reported by participants in 
each condition? 
To analyze the exploratory aim process measure, The Patient Global Impression 
of Improvement, linear mixed effects modeling was utilized. Growth curves were 
calculated in three models: 1) the entire sample size, irrespective of conditions, 2) split 
into conditions as the main effect, and 3) split into conditions and measured across time 
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for the interaction.  
 
4.9 Effect Sizes and Power Analysis 
While researchers often only report p values to indicate statistical significance, 
this can be a limitation. Further, effect sizes are typically not reported unless the p values 
are significant. P values depend to some degree on standard error; a larger sample size 
decreases standard error and lowers the p value (Altman & Bland, 2005). In fact, a 
statistically significant p value, according to Tomczak and Tomczak, sometimes “mainly 
indicates that a huge sample size was used” (2014, p. 20; Bradley & Brand, 2013; 
Sullivan & Feinn, 2012). P values as such do not indicate the strength of the relationship 
between the variables (Fritz, Morris, & Richler, 2012). Thus, Tomczak and Tomczak 
(2014) recommend reporting the effect size estimates alongside null findings.  
 
4.10 Study Challenges and Limitations 
The use of HEP as a comparison condition brings study design limitations. 
Additional remuneration is needed when executing a comparison condition. Using HEP 
may increase cost and participant obligation in a larger scale study. While acknowledging 
participant burden present in the intervention and comparison conditions, it is important 
to note that UUI is not a simple condition and it is unlikely to be treated with an 
insubstantial intervention. These interventions are equally burdensome and they are 
clinically recognized strategies. When using MBSR, HEP is the gold standard 
comparison condition. The advantages and disadvantages of implementing HEP as a 
comparison condition are summarized in Section 4.12.1. 
96 
 
While MBSR or HEP is increasingly prevalent as a treatment modality for many 
other conditions, it is important to note that this study is only generalizable to those 
willing and able to participate.  
Recruitment in clinical intervention studies is always a challenge. I recruited 
through multiple sources and modalities. This included a need for a second IRB 
application associated with a separate sampling source outside the university. Having 
postmenopausal status as a requirement limited my recruitment yet provided me with 
potential participants in the needed age range. As this is a pilot feasibility study, I 
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4.12 Supplemental Information 
4.12.1 Rationale for Choosing HEP Comparison Condition 
Table 3 Rationale for Choosing HEP Comparison Condition. 
Study design 





 Easier recruitment 
 Less expensive intervention 
 Less difficult recruitment (no 
randomization) 
 Potentially better retention 
rates as there is no question 
about which intervention is the 
“real” one 
 
 Carries less weight 
 Potential positive differences measured 
could be explained by alternate 
justifications (e.g., social interaction or 
support) 
 Unlikely to be published without a 
comparison condition 
 Study appears less robust without a 




 All participants eventually 
receive the actual MBSR 
treatment 
 Same instructor for all 
participants 
 Improves adherence 
 Reduces attrition (MacCoon et 
al., 2012) 
 
 Control only; no actual comparison offered 
to the main intervention  
 Still a weak study design 
 Would require as much recruiting/enrolling 
as using a more vigorous comparison 
condition  
 As expensive as the HEP, since all 
participants will receive intervention 
 MBSR is already shown to improve mental 
and physical health compared to waitlist 
controls, and TAU (Barnhofer et al., 2007; 
Davidson et al., 2003; Gregg, Callaghan, 
Hayes, & Glenn-Lawson, 2007; Kabat-Zinn 
et al., 1998; Ma & Teasdale, 2004; Pradhan 
et al., 2007; Speca, Carlson, Goodey, & 
Angen, 2000) 
 Study appears weaker without a 
comparison condition of the same 
structure/rigor 
 Introduces a number of confounders that 
make it difficult to accurately interpret the 





 Does not “ask” as much from 
the comparison condition 
participants; perhaps carries 
less ethical concerns as I am 
not asking for as deep of a time 
commitment  
 Still randomized 
 Probably cheaper 
 Not a good comparison condition as the 
time/ participant investment required is 
unequal between conditions 
 Less contact with providers 
 Less contact with other participants in same 
condition 
 Differences between interventions may 
instead be a result of structural 
nonequivalencies rather than the 
mechanism of interest 
 Possibly different instructor 
 Study appears feebler without a comparison 
condition of the same configuration 
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Table 3 Continued  
Study design 





 Structurally equivalent to 
MBSR (number and duration 
of sessions, therapist training 
and qualifications, format of 
the therapy [i.e., condition], 
and the ability of participants 
to discuss their particular 
problems) (MacCoon et al., 
2012) 
 Validated instrument 
(MacCoon et al., 2012) 
 Provides a necessary 
foundation for providing 
rigorous investigation of 
relative efficacy of MBSR 
(arguably not applicable as my 
study is primarily a feasibility 
study) 
 Answers NIH’s 2008 call to 
provide comparison condition 
to MBSR studies that is of 
equivalent commitment and 
experience (Ospina et al., 
2008) 
 Active control which remains 
inert to mindfulness 
 While it is a substantial 
commitment to ask from 
participants, it is still 
“equivalent” to the MBSR 
commitment  
 Delivers “skillful provision of 
common therapeutic elements” 
so as to not bias tests of 
intervention effects (Mohr et 
al., 2005) 
 Includes all nonspecific factors 
present in MBSR 
 Designed to match MBSR in 1) 
positive expectations of 
success by teacher and 
participant, 2) an ongoing 
relationship between teacher 
and participant, 3) a conceptual 
framework supporting 
participant’s actions, 4) 
specific actions and 
instructions for participant to 
follow (Kok et al., 2013) 
 Provides plausible alternative 
for success through therapeutic 
rationale 
 Substantial (even intense) commitment 
from participants 
 Makes future intervention design and 
accompanying funding less likely as it 
reduces scalability 
 Moving forward to full RCT will be 
difficult due to considerations of cost and 
participant commitment   
 Additional compensation needed to 
remunerate participants 
 Different instructor 
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4.12.2 Curricula Comparison of Mindfulness-Based Stress Reduction  
and Health Enhancement Program  
Table 4 Curricula Comparison of Mindfulness-Based Stress Reduction  
and Health Enhancement Program  
Session (weekly) MBSR content HEP content 
1 Week 1 Simple Awareness 
 
History of MBSR; Overview of 
MBSR in science and medical 
research; Risks and benefits; 
Guided mindful eating exercise; 
Guided Body Scan meditation 
 
Physical Activity/ Functional Movement 
and Music Therapy 
 
Problems in Improving Health: Focuses 
on physical fitness, functional 
movement exercises, and music and 
imagery 
2 Week 2 Attention and the Brain 
 
Guided body scan meditation; 
Guided introduction to sitting 
meditation; Role of perception and 
conditioning in the appraisal and 
assessment of stress 
 
Physical Activity/ Functional Movement 
and Music Therapy 
 
Physical Activity to Enhance Well-
being: Physical activities focus on 
posture and alignment as ways to 
optimize function 
3 Week 3 Dealing with Thoughts 
 
Guided body awareness and 
mindful movement practice and 
guided seated meditation practice; 
Guided body awareness and 
mindful movement practice; 
Guided seated meditation; Guided 
discussion regarding the tendency 
of the mind to label events as 
pleasant or unpleasant instead of 





Understanding Dietary Guidelines: 
Participants engage in a lecture and 
discussion series about basic nutrition 
principles; diet journaling is reviewed 
and demonstrated as a way to better 
understand healthy food choices  
4 Week 4 Stress: Responding vs. Reacting 
 
Guided preparatory body 
awareness and mindful movement 
practice and guided seated 
meditation practice; Continued 
guided discussion regarding the 
tendency of the mind to label 
events as pleasant or unpleasant 








Fine-tuning Dietary Choices: 
Participants learn the use of the USDA 
My Pyramid Food Tracker Program and 
behavioral changes are discusses as a 
way to meet dietary goals 
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Table 4 Continued   
Session (weekly) MBSR content HEP content 
5 Week 5 Dealing with Difficult 
Emotions/Sensations 
 
Guided sitting meditation and 
walking meditation; Skill means 
of working with observed stress 
reactivity 
Physical Activity/ Functional Movement 
and Music Therapy 
 
Adapting to an Unpredictable 
Environment - Part I: Activities focus 
on functional movement and alignment; 
supportive music imagery focuses on 
responding to the environment in 
creative ways 
 
6 Week 6 Mindfulness and Communication 
 
Guided sitting meditation 
practices; Guidance through 
assertive communications 
strategies 
Physical Activity/ Functional Movement 
and Music Therapy 
 
Adapting to an Unpredictable 
Environment - Part II: Activities such 
as walking, jogging, and stretching are 
discussed as participants are 
encouraged to respond to the 
environment in creative ways to 
enhance well-being 
 
7 (6b: Retreat between 
weeks 6 and 7) 
In this day-long session, the 
learner will deepen the various 
mindfulness practices, and 
strengthen the flexible capacity to 
utilize mindfulness in multiple 
real-life situations 
 
Spa Day  
 
work with all practices, group 
discussion and exercises  
8 Week 7 Mindfulness and Compassion 
 
Guided body awareness and 
mindful movement; Guided sitting 
meditation focusing on the 
observation of thoughts 
Physical Activity/ Functional Movement 
and Music Therapy 
 
Responding to the Environment in 
Creative Ways: Participants learn the 
kinetic chain of functional movement 
and build group cohesion through group 
songwriting exercises 
 
9 Week 8 Conclusion 
 
 
Guided body scan meditation, 
guided sitting meditation 
Physical Activity and Functional 
Movement  
 
Support for Continuing Practice: 
Participants review the course and plan 
for maintaining gains including all 






4.12.3 Incontinence Severity Index (ISI)  
Participant ID: ____________________________ Date: _________  
Please answer the following 2 questions.  
1. How often do you experience urinary leakage? (Please check one) 
 ___ Never, I do not leak urine  
___ Less than once a month  
___ A few times a month  
___ A few times a week  
___ Every day and/or night  
2. How much urine do you lose each time? (Please check one)  
___ None, I do not leak urine  
___ Drops  
___ Small Splashes  
___ More  




4.12.4 Incontinence Questions 
How can I know what type of incontinence I have? To assess your bladder problems, 
you can ask yourself the following questions: 
1. During the last 3 months, have you leaked urine (even a small amount)? 
� Yes (continue to question 2) � No (done – no urge incontinence) 
2. During the last 3 months, did you leak urine: 
(Check all that apply) 
� When you performing some physical activity, such as coughing, sneezing, lifting 
or exercise? 
� When you had the urge or the feeling that you needed to empty your bladder, but 
you could not get to the toilet fast enough? 
� Without physical activity and without a sense of urgency? 
3. During the last 3 months, did you leak urine most often: 
(Check only one) 
� When you performing some physical activity, such as coughing, sneezing, lifting 
or exercise? 
� When you had the urge or the feeling that you needed to empty your bladder, but 
you could not get to the toilet fast enough? 
� Without physical activity and without a sense of urgency? 
� About equally as often with physical activity as with a sense of urgency? 
Response to #3 Type of Incontinence 
Most often with physical activity  Stress only or mostly stress 
Most often with the urge to urinate  Urge only or mostly urge 
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Without activity or urgency   Other cause 




4.12.5 Montreal Cognitive Assessment and Instructions  
 














4.12.6 Screening Script 
Thank you for calling. I’m Katarina Felsted and I’m a full time faculty member in the 
College of Nursing at the University of Utah. I am also a third year PhD student and the 
project you have expressed interest in is my dissertation research.  
Would you be so kind to let me know where you heard about my project? [Note 
information for recruitment tracking] 
My research focus is using integrative or alternative therapies to treat chronic 
conditions in older adults. I am conducting a study using two types of complementary 
integrative therapies to treat urge urinary incontinence in older adult women.  
Does this sound like something you may be interested in? 
[If No:] Thank you so much for your time. You are more than welcome to pass my 
number along to someone else you think may be interested and they can call me.  
[Yes: continue below] 
This study will randomize participants into one of two groups. Both groups will meet 
for about two hours a week, for eight weeks. During week six, there will also be a half-
day education retreat. These groups are educational and behavioral in nature; we will not 
be administering any type of medication and we will not be drawing any labs.  
We will meet each time at the College of Nursing on the University of Utah campus, 
and I will provide you with parking validations or public transportation passes, whichever 
suits you best.  
You will also receive a $100 gift card as compensation for your time [can clarify $40 
after retreat and $60 after completion of study measures if asked].  
You can stop the study at any time. You are not obligated to attend or finish. You 
may or may not receive any direct benefit from participation. These types of studies are 
important to move our understanding of incontinence in older women forward.  
I will be at every session each week, and I’ll be checking in with you every so often 
during the intervention.  
I would like to go through the eligibility criteria with you. I will list the item and you 
can let me know if you have any questions about it. Then we will move on to the next.  
[read each eligibility criterion] 
Can I help explain any of those further?  
Are there other approaches you have tried in managing your UUI? 
I also have a list of exclusion criteria that I would like to go through with you. These 
may exclude you from participating. Please stop me at any time if you have a question.  
[read each exclusion criterion] 
Do you have any questions about any of these items? 
That’s wonderful. I would like to schedule an enrollment interview with you. At that 
time, I will review the informed consent document, explain which group you will be 
selected to participate in, your compensation, and answer any questions you may have.  
Will you be driving or taking public transportation?  
I will send you an address and directions. You have my phone number and are 
welcome to call me any time. I will meet you at the trax stop/ bus stop/ parking garage 
and show you how to find the building. Our meeting will take about an hour. I look 
forward to seeing you!  
What day and time is convenient for you in the next few days? May I have your 
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permission to leave messages on your voice mail, or do you prefer texting? 
[obtain contact information (all phones and email), set appointment, send directions 





4.12.7 Group Guidelines 
 I want a safe class to share my feelings and experiences; therefore, I promise 
confidentiality. I will not use names or identifying information of other class 
members in discussions outside of this class.  
 
 I understand the importance of consistency; therefore, I will attend each class. 
 
 I want my class to start and end on time; therefore, I will come on time and leave 
when the class is over. 
 
 I understand that this is a closed class and will not bring friends or relatives with 
me.  
 
 I recognize that my needs are important and in this class I have an opportunity to 
learn and share. 
 
 I will allow others their feelings and listen with caring and trust in their process. 
Everyone’s experience is unique and important. 
 
 I grow best when I’m present for myself; therefore, I will not use alcohol or drugs 
before class. 
 

















After, K. P. Supiano, 2015 
Grief Support Group Manual, University of Utah-College of Nursing 
M. Caserta, personal communication, 20 June 2016  
121 
 
4.12.8 Demographics Questionnaire 
 
Thank you for providing the following data. Please mark each item clearly.  
Participant ID _____________________________________________ Date _________ 
 
1. What is your date of birth? ___________________________________________ 
(month, date, year) 


















4. Please indicate your height _____ feet  _____ inches 
 
5. Please indicate your weight _____ lbs  
 
6. What is the highest degree or level of school you have completed? 
 
– 8th grade 
 







7. Have you ever been pregnant? 
 
 
If yes, how many deliveries have you had? ______ 
 
8. Please indicate age at onset of menopause: ______ years 
 







11. Are you currently dealing with major family or life stressor such as job loss, death, 
 
 








13. How many different prescription medications, not including vitamins, are you 
currently taking? ______ 
 
14. Please indicate if you are taking medication for: 
 medication for depression or anxiety  
 
 
-blockers for heart disease  
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4.12.9 Study Measures Overview 
Table 5 Study Measures Overview 
Component Measure Time of measurement 
Demographics Standard demographic 
questionnaire 
At baseline; caffeine and medication use 
will also be recorded again at completion  
Research Feasibility   
Recruitment Number enrolled (% of 
contacted); from 
where/how recruited; also 
document why those who 
didn’t enroll chose not to 
During recruitment phase 
Retention Number who completed 
intervention; document 
attrition reasons if given  
Tracked from time of consent through 
completion of study 
Treatment Fidelity Treatment integrity 
objectives met 
After each session in a brief meeting with 
the interventionist 
At completion of study with a checklist 
filled out by participants  
Intervention Feasibility   
Acceptability + vs - response, verbal 
approach and recorded 
feedback 
After each session of treatment condition 
and comparison condition with randomly 
selected participants 
Tolerability Drop out count, open 
ended exit interview 
Evaluated from beginning of study through 
study completion 
Treatment Adherence Attendance and homework 
completion 
At each session of treatment condition and 
comparison condition, measured by 
interventionist  





Part 1 of Overactive 
Bladder Questionnaire 
Short Form (Q1-6) 





Questionnaire Short Form  
Overall and Part 2 (HRQL) 
specifically 
At baseline and at study completion, by 
participant 
Perceived Stress  
(Outcome Measure) 





Index of Urinary 
Incontinence 
At baseline and at study completion, by 
participant 
Rate and Trajectory of 
Change (Process 
Measure) 
Patient Global Impression 
of Improvement (PGI-I) 
After each session of treatment and 





4.12.10 Overactive Bladder Questionnaire Short Form Symptom  
Bother (OAB-q SF) 
This questionnaire asks about how much you have been bothered by selected 
bladder symptoms during the past 4 weeks. Please circle the number that best describes 
the extent to which you were bothered by each symptom during the past 4 weeks. There 
are no right or wrong answers. Please be sure to answer every question. 
 
Participant ID _____________________________________________ Date _________ 
 
1 = Not at all. 2 = A little bit. 3 = Somewhat. 4 = Quite a bit. 5 = A great deal.  
6 = A very great deal. 
During the past 4 weeks, how bothered were you by: 
1. An uncomfortable urge to urinate?    1     2     3      4     5     6 
2. A sudden urge to urinate with little or no warning?  1     2     3      4     5     6 
3. Accidental loss of small amounts of urine?   1     2     3      4     5     6 
4. Nighttime urination?      1     2     3      4     5     6 
5. Waking up at night because you had to urinate?  1     2     3      4     5     6 




For the following questions, please think about your overall bladder symptoms in 
the past 4 weeks and how these symptoms have affected your life. Please answer each 
question about how often you have felt this way to the best of your ability. 
Please answer each question using this scale:  
1 = None of the time. 2 = A little of the time. 3 = Some of the time.  
4 = A good bit of the time. 5 = Most of the time. 6 = All of the time.  
 
During the past 4 weeks, how often have your bladder symptoms: 
1. Caused you to plan “escape routes” to restrooms in public places? 1    2    3     4    5    6 
2. Made you feel like there is something wrong with you?                  1    2    3     4    5    6 
3. Interfered with your ability to get a good night’s rest?                    1    2    3     4    5    6 
4. Made you frustrated or annoyed about the amount of time you spend in the restroom? 
                                                                                                             1    2    3      4    5    6 
5. Made you avoid activities away from the restroom (i.e., walks, running, hiking)?   
                                                                                                             1    2    3      4    5    6 
6. Awakened you during sleep?                                                          1     2    3    4    5     6  
7. Caused you to decrease your physical activities (exercising, sports, etc.)?  
                                                                                                             1    2    3      4    5    6 
8. Caused you to have problems with your partner or spouse?           1    2    3      4    5    6 
9. Made you uncomfortable while traveling with others because of needing to stop for a 
restroom?                                                                                       1    2    3      4    5    6 




11. Interfered with getting the amount of sleep you needed?              1    2    3      4    5    6 
12. Caused you embarrassment?                                                          1    2    3      4    5    6 
13. Caused you to locate the closest restroom as soon as you arrive at a place you have 




4.12.11 Perceived Stress Scale 
The questions in this scale ask you about your feelings and thoughts during the 
last month. In each case, you will be asked to indicate by circling how often you felt or 
thought a certain way. 
 
Participant ID _____________________________________________ Date _________ 
 
0 = Never 1 = Almost Never 2 = Sometimes 3 = Fairly Often 4 = Very Often 
1. In the last month, how often have you been upset because of something that happened 
unexpectedly?      0  1  2  3  4 
 
2. In the last month, how often have you felt that you were unable to control the 
important things in your life?    0  1  2  3  4 
 
3. In the last month, how often have you felt nervous and “stressed”?  
0  1  2  3  4 
 
4. In the last month, how often have you felt confident about your ability to handle your 
personal problems?      0  1  2  3  4 
 
5. In the last month, how often have you felt that things were going your way?   
       0  1  2  3  4 
6. In the last month, how often have you found that you could not cope with all the things 
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that you had to do?      0  1  2  3  4 
 
7. In the last month, how often have you been able to control irritations in your life?  
       0  1  2  3  4 
 
8. In the last month, how often have you felt that you were on top of things?  
        0  1  2  3  4 
9. In the last month, how often have you been angered because of things that were outside 
of your control?      0  1  2  3  4 
 
10. In the last month, how often have you felt difficulties were piling up so high that you 




4.12.12 Geriatric Self-Efficacy Scale for Urinary Incontinence (GSE-UI) 
4.12.12.1 Study Enrollment Time  
Participant ID _____________________________________________ Date _________ 
How confident are you that you can hold your 
urine . . . .  
0 = Not very confident 
10 = Very confident 
0---------------5-------------------10 
When you are at home and have to go to the 
bathroom? 
0    1    2    3    4    5    6    7    8    9    10 
When you are away from home? 0    1    2    3    4    5    6    7    8    9    10 
Long enough to get to the bathroom in time during 
the night? 
0    1    2    3    4    5    6    7    8    9    10 
For at least 20 minutes when you feel the urge? 0    1    2    3    4    5    6    7    8    9    10 
When coughing? 0    1    2    3    4    5    6    7    8    9    10 
When sneezing?  0    1    2    3    4    5    6    7    8    9    10 
When laughing?  0    1    2    3    4    5    6    7    8    9    10 
When you are nervous? 0    1    2    3    4    5    6    7    8    9    10 
How confident are you that you can . . . 
Visit places where you may have difficulty 
locating the bathroom? 
0    1    2    3    4    5    6    7    8    9    10 
Go out on social outings without worrying about 
urine loss? 
0    1    2    3    4    5    6    7    8    9    10 
Prevent urine loss without relying on pads or 
protection when you are at home? 
0    1    2    3    4    5    6    7    8    9    10 
Prevent urine loss without relying on pads or 
protection when you are out? 
0    1    2    3    4    5    6    7    8    9    10 
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Implement the elements of what you will learn to 
manage your urine control?  




4.12.12.2 Study Completion Time  
Participant ID _____________________________________________ Date _________ 
How confident are you that you can hold your 
urine . . . .  
0 = Not very confident 
10 = Very confident 
0---------------5-------------------10 
When you are at home and have to go to the 
bathroom? 
0    1    2    3    4    5    6    7    8    9    10 
When you are away from home? 0    1    2    3    4    5    6    7    8    9    10 
Long enough to get to the bathroom in time during 
the night? 
0    1    2    3    4    5    6    7    8    9    10 
When coughing? 0    1    2    3    4    5    6    7    8    9    10 
When sneezing? 0    1    2    3    4    5    6    7    8    9    10 
When laughing?  0    1    2    3    4    5    6    7    8    9    10 
For at least 20 minutes when you feel the urge? 0    1    2    3    4    5    6    7    8    9    10 
When you are nervous? 0    1    2    3    4    5    6    7    8    9    10 
How confident are you that you can . . . 
Visit places where you may have difficulty 
locating the bathroom? 
0    1    2    3    4    5    6    7    8    9    10 
Go out on social outings without worrying about 
urine loss? 
0    1    2    3    4    5    6    7    8    9    10 
Prevent urine loss without relying on pads or 
protection when you are at home? 
0    1    2    3    4    5    6    7    8    9    10 
Prevent urine loss without relying on pads or 
protection when you are out? 
0    1    2    3    4    5    6    7    8    9    10 
Implement the elements of what you have learned 
to manage your urine control?  




4.12.13 Patient Global Impression of Improvement  
Participant ID _____________________________________________ Date _________ 
PGI-I: Patient Global Impression of Improvement  
Compared to how your urinary control was at admission to the project, do you feel 
that you are:  
  Very much better  
  Much better  
  Better  
  About the same  
  Worse  
  Much worse  






4.12.14 CONSORT Flow Diagram  
 
Figure 2 CONSORT Flow Diagram for Comparing Mindfulness-Based Stress 
Reduction With the Health Enhancement Program in the Treatment of Urge Urinary 












DESIGNING RIGOROUS METHODS IN INTEGRATIVE RESEARCH: 
COMPARING MINDFULNESS-BASED STRESS REDUCTION  
WITH THE HEALTH ENHANCEMENT PROGRAM IN THE  
TREATMENT OF URGE URINARY INCONTINENCE IN  
OLDER ADULT WOMEN: A PILOT FEASIBILITY  
AND RANDOMIZED CONTROLLED  
TRIAL (SHUW) 
 
Katarina Friberg Felsted, MS1 
Katherine Perry Supiano, PhD, LCSW, FT1 






Older adult women are marginalized in scientific research. Prior research has been 
done studying the treatment of urinary urge incontinence through mindfulness-based 
stress reduction. The highest prevalence of urinary urge incontinence is found in older 
adult women, yet this is the first study to treat older adult women with urge urinary 
incontinence with mindfulness-based stress reduction.  
A rigorous pilot feasibility and randomized controlled trial is described from 
study design through follow-up. Preparations, procedures, and execution of the study 
including measures, data management, and statistical analyses are delineated. 
Considerations necessary due to the specific population are explained.   
Authors discuss significant characteristics, anticipated results, as well as 
successes and difficulties embedded in the methods used.  
 
5.2 Background  
5.2.1 Rationale 
Symptoms of urinary leakage with urgency (known as urge urinary incontinence, 
or UUI) are common, disproportionately affect older women, and can be socially and 
psychologically devastating. Mindfulness-based stress reduction (MBSR) appears to be a 
favorable therapy for some women with UUI.1,2 The overarching goal of this research 
was to evaluate potential treatment options for older women with symptoms of UUI, with 
a specific focus on MBSR, a promising therapeutic approach in preliminary studies and 
one increasingly used to treat symptoms associated with brain-visceral interactions.3,4 
The research protocol described here evaluated the feasibility and preliminary 
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efficacy of treating UUI in older adult women with MBSR in comparison to the health 
enhancement program (HEP), a validated educational intervention, through a combined 
pilot study and randomized controlled trial.5 Feasibility studies are an essential step in the 
translation of evidence-based interventions to broader implementation. Feasibility 
determinants included both research feasibility (recruitment, retention, treatment fidelity) 
and intervention feasibility (acceptability, tolerability, treatment adherence). Clinical 
outcomes to evaluate preliminary intervention efficacy included severity of UUI 
symptoms, bother of UUI symptoms, perceived stress, and perceived level of self-
efficacy of self-management of UUI symptoms. Preliminary efficacy of the intervention 
was also evaluated. 
 
5.2.2 Hypothesis 
The capacity for hypothesis testing, or establishing causal inference may be 
limited in a pilot study due to insufficient power; however, the information from efficacy 
testing is vital in informing future larger scale clinical trials.6 This study served as a 
necessary step for the development of effectiveness trials of MBSR in treatment of UUI 
in older adult women by informing and guiding evaluation, intervention implementation, 
and dissemination of findings. As this was a pilot feasibility study, a small sample size 
was anticipated and hypothesis testing was conducted as an exploratory aim. 
 
5.2.3 Objectives 
 Aim 1: To determine the research feasibility of an RCT comparing MBSR and 
HEP in older adult women presenting with UUI, measured by recruitment, 
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retention, and treatment fidelity.  
 Aim 2: To determine the intervention feasibility of an RCT comparing MBSR 
and HEP implementation in older adult women presenting with UUI, 
measured by acceptability, tolerability, and treatment adherence. 
 Exploratory aim: To evaluate short term preliminary efficacy of MBSR for 
treatment of UUI in older adult women, in comparison to HEP, measured by 
symptom severity, symptom bother, perceived stress, perceived self-efficacy, 
and the trajectory of change. 
 
5.3 Methods 
5.3.1 Study Design 
 Participants were recruited from the university health care system as well as from 
select places in the community. They were consented, enrolled, randomized and then 
outcome measures were administered at the enrollment to have baseline data. Participants 
participated in one of two treatment conditions, and weekly process measures were 
administered throughout each week. At completion of the intervention conditions, the 
outcome measures that had been administered at enrollment were once again 
administered. See Figure 3.  
 
5.3.2 Procedures 






5.3.2.1 Recruitment  
Recruitment of older adults carries particular challenges and can be improved by 
cultivating relationships with community-based organizations, face-to-face contact with 
potential study participants, and providing service as an access point to eligible 
participants.7 Pilot sample size should be based on “the pragmatics of recruitment and the 
necessities for examining feasibility.”6 To minimize the risk of embarrassment from 
participating in the project, the study was advertised as a “Bladder health” study. 
Participants were recruited from the University’s Health Care System, including a 
geriatrics and pelvic disorder clinic, the Osher Lifelong Learning Institute on campus, 
where older adults attend to learn about a variety of subjects, and two research participant 
registries within the Health Sciences Center. These areas were utilized for recruitment in 
prior similar studies and were chosen as locations that would be accessed by older adults. 
Recruitment also included county senior centers, which necessitated an additional 
Institutional Review Board application, through the State Department of Health and 
Human Services. Success rates of various recruitment strategies were tracked. 
 
5.3.2.2 Screening 
When potential participants contacted study personnel, the framework of the 
study, the time commitment, transportation options, and remuneration were explained. 
For the purposes of transparency and reproducibility, a screening script was followed (see 
4.12.6). When the participant expressed interest, the eligibility and exclusion criteria 
were reviewed (see 4.3.1). When a potential participant qualified for the study, she was 
invited to come in for an enrollment interview. All qualified participants who were 
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invited to come in for an interview did so. 
 
5.3.2.2.1 Informed Consent  
Potential participants who met the eligibility criteria were provided with an 
informed consent document, as well as a study summary highlighting the key features in 
a one-page document. The consent document was reviewed with participants paragraph 
by paragraph. Participants were informed of the confidentiality guidelines of participation 
and given a copy of the consent document. 
 
5.3.2.2.2 Enhanced Enrollment 
Upon obtaining informed consent, the Montreal Cognitive Assessment8 (MoCA) 
(see 4.12.5) was administered and, as appropriate, administration of the baseline 
measures proceeded. Enrolled participants were informed of their assigned intervention 
while preserving the blinded-to-condition nature of the study design. 
 
5.3.2.2.3 Randomization 
As outlined in the Consolidated Standards of Reporting Trials (CONSORT),9,10 
participants were randomized into the MBSR or HEP condition according to the order of 
enrollment, and randomization was generated through the block method to ensure that 
enrollment was generated with a 1:1 ratio, with varied block sizes. The PI and the bio-
informatician generated the randomization. The randomized allocation was presented in a 
sealed envelope during enrollment and opened by the consented participant. Participants 
were blinded to the study condition. This was done to adhere to CONSORT guidelines 
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and potentially diminish dropout rates in the comparison condition.9,10 
 
5.3.2 Sample 
Twenty-five postmenopausal females were recruited as participants into this 
study. The target range of enrollment was 12-30 participants. This number was chosen to 
practically achieve meaningful intervention condition size and to be consistent with pilot 
studies on bio-behavioral interventions delivered in a group format. This range was also 
recommended by interventionists (Vicki Overfelt, personal communication, November 
30, 2016; Amy Stevenson, personal communication, January 17, 2017).   
 
5.3.3 Treatments 
The interventionists in these two study conditions were certified and credentialed. 
Because of the sensitive nature of the UUI condition, female interventionists were hired 
for both treatment arms. 
 
5.3.3.1 Mindfulness-Based Stress Reduction (MBSR)  
Mindfulness-Based Stress Reduction is an 8-week psychosocial intervention 
delivered in a group setting. Participants attend 9 total sessions, meeting for 2 hours each 
week for 8 weeks, with a retreat between weeks 6 and 7. Class instruction is augmented 






5.3.3.2 Health Enhancement Program (HEP) Comparison Condition 
The HEP protocol is a substantive active comparison condition, which delivers 
“skillful provision of common therapeutic elements,”5 so as to not bias tests of 
intervention effects.11 It is credible to both participants and providers and offers a 
plausible alternative for success through therapeutic rationale. Identical to MBSR in its 
format, participants meet in 9 sessions, 2 hours a week for 8 weeks, with a retreat 
between weeks 6 and 7. Class instruction in four basic categories is supplemented with 
weekly homework, much like the MBSR practice (Table 3). 
 
5.3.3.3 Rationale for Selection of the Comparison Condition 
The HEP condition is responsive to the US National Institutes of Health’s call to 
researchers to provide a comparison condition for MBSR studies that is of equivalent 
commitment and experience (Table 2).12 
 
5.3.4 Assessments 
5.3.4.1 Demographics  
Demographic collection at baseline included date of birth, race/ethnicity, height 
and weight to calculate BMI, marital status, education, brief gynecologic and medical 
history, brief UUI history, medication use, caffeine intake, life satisfaction, and life 
stress. Caffeine use and medication was recorded again at completion of study, to 





5.3.4.2 Feasibility Measures 
The feasibility measures are divided into research feasibility measures, having to 
do with research process, and intervention feasibility measures, having to do with 
participant process and outcome (see 4.12.9).  
 
5.3.4.2.1 Research Feasibility Measures 
Recruitment was measured as number of people enrolled, and referral source was 
noted.13 The ratio of contacted to enrolled was also calculated, and reasons for exclusion 
(by researcher) or declining (by respondent) were recorded.   
Retention was measured as percent of enrolled participants completing the study 
and accounted for reasons for attrition.14 If a participant did not attend a session, a 
courteous follow-up telephone call was placed, exploring what the attendance challenge 
may have been. These data were recorded in field notes and the information was handled 
as protected data.  
Treatment delivery was measured by consulting with the interventionists after 
each session, to confirm that treatment integrity objectives were met. A 75% or higher 
achievement on these objectives was considered the standard confirming objectives being 
met.15 Treatment delivery was also measured by a checklist given to participants at study 
completion, to mark those concepts covered in the weekly interventions. A 75% or higher 
achievement on these participants’ reports is typically the standard to confirm the 





5.3.4.2.2 Intervention Feasibility Measures 
Acceptability was measured as a positive versus negative response to the question, 
“How did it go today?” Following each session, 2 randomly selected participants in each 
intervention were approached by the PI and assessed on this acceptability question. Each 
qualitative response was coded quantitatively as a negative or a positive response and the 
aggregate data was analyzed. 
Tolerability was measured as number of dropouts due to stated distress from or 
dislike of either intervention experience, as opposed to someone needing to withdraw due 
to a family emergency or illness.16,17 Participants who withdrew were asked to respond to 
a single question, “Help me understand what made this challenging?”  
Treatment adherence was measured by attendance and homework completion at 
each session, as recorded by the interventionists and confirmed by the PI.  
 
5.3.4.3 Preliminary Efficacy Measures 
5.3.4.3.1 Outcome Measures 
The 4 measures of outcome preliminary efficacy, the Incontinence Severity Index 
(ISI), the Overactive Bladder Questionnaire Short Form (OAB-q SF), the Perceived 
Stress Scale (PSS), and the Geriatric Self-Efficacy Index for Urinary Incontinence (GSE-
UI), were administered at baseline and again at study completion. The ISI and OAB-q 
were selected from the literature examining UUI. The PSS and the GSE-UI were selected 
as they were theoretically driven. These measures had to be ≥ 75% completed to be 
included in data analysis.  
5.3.4.3.1.1 Incontinence Severity Index (ISI). 2-item scale. The Incontinence 
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Severity Index18,19 is a short, simple, and sensitive measure of severity of urinary 
incontinence in women with reported Cronbach’s α coefficient = 0.93 (see section 
4.12.3).  
5.3.4.3.1.2 Overactive Bladder Questionnaire Short Form (OAB-q SF). 19 item 
scale. The Overactive Bladder Questionnaire Short Form20 measures symptom bother as 
well as severity to some extent on a Likert-type scale from 1 (not at all) to 6 (a very great 
deal) with higher score relating to higher bother. The OAB-q is able to differentiate 
between participants with and without overactive bladder incontinence and has reported 
Cronbach α values ranging from 0.86 to 0.94 (section 4.12.10).  
5.3.4.3.1.3 Perceived Stress Scale (PSS-10). 10-item scale. The Perceived Stress 
Scale21-23 measures stress in the last month on a Likert-type scale from 0 (never) to 4 
(very often). Scores range from 0 to 40; higher scores relate to higher levels of perceived 
stress. Cohen and colleagues state that the PSS demonstrates “substantial reliability and 
validity”21 and presented coefficient Reported Cronbach α values were 0.84, 0.85, 0.86 in 
3 samples (see Section 4.12.11).21  
5.3.4.3.1.4 Geriatric Self-Efficacy Index for Urinary Incontinence (GSE-UI). 13 
item scale; adapted. The GSE-UI measures self-efficacy with regard to urinary 
incontinence in 65 and older. The GSE-UI has a sensitivity of 0.75, a specificity of 0.78, 
and a reported Cronbach’s α = 0.90.24,25 Scores range from 0 to 130 and responses are 
recorded on a Likert-type scale from 0 (not confident) to 10 (very confident) (section 





5.3.4.3.2 Process Measure  
5.3.4.3.2.1 Patient Global Impression of Improvement (PGI-I). 1-item Scale. To 
inform a future, larger scale trial, we noted the trajectory of participant-perceived change. 
Each participant completed a Patient Global Impression of Improvement scale after each 
session. The PGI-I has been validated specifically in incontinence and that it shows 
“excellent test-retest reliability.”26 The PGI-I was administered after each of the 9 
sessions (see Section 4.12.13).  
 
5.3.5 Follow-up 
A 6-month follow-up was scheduled with participants to repeat outcome and 
process measures. At that time, a semistructured qualitative interview was conducted.  
 
5.3.6 Timetable 
The timetable of this study was approximately 1 year. IRB approvals were 
obtained over a 5-month period. Recruitment and enrollment ensued for 10 weeks. The 
study itself, with both the treatment and comparison conditions separately receiving the 
intervention, lasted 8 weeks. Data entry, export, and analysis followed over the next 3 
months.   
 
5.3.7 Safety Consideration 
All attempts to safeguard confidentiality were made using technological and 
physical precautions. Participants were assigned a study identification number to 
maintain a confidential environment. Both the CONSORT8,9 and Standard Protocol Items: 
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Recommendations for Interventional Trials (SPIRIT) guidelines were followed with 
respect to confidentiality.8 In addition, privacy and confidentiality considerations were 
reviewed with each participant individually at enrollment and in each study condition as 
discussed by the respective interventionist.8 
 
5.3.8 Quality Assurance 
Good clinical practices, encompassing research staff training, informed consent 
procedures, Institutional Review Board (IRB) reporting, and monitoring/oversight 
procedures of both interventionists and participants, were strictly adhered to in the 
study.27,28 
 
5.3.9 Data Management 
Data were collected in paper form and entered and electronically managed in 
Research Electronic Data Capture (REDCapTM), a secure, web-based application 
intended to support data capture for research studies. Data were exported to IBM SPSS 
version 24.0 and STATA for data analysis.29,30  
 
5.3.10 Statistical Analysis 
There were 5 components to the analytic plan: analysis of demographics, research 
feasibility measures, intervention feasibility measures, outcome measures, and the 
process measure organized by aims below. Preanalysis of demographic data was 




5.3.10.1 Aim 1  
To determine the research feasibility, determinants included recruitment, 
retention, and treatment fidelity.  
Data analysis for the recruitment and retention portions of this aim were 
performed through descriptive statistics, displayed in a CONSORT flowchart illustrating 
the number of participants who were screened, met eligibility/exclusion criteria, enrolled, 
consented, participated, and completed the study (see Section 4.12.14). Data addressing 
reasons why potential participants were ineligible, why participants were not consented 
(exclusion and declining), and reasons for participant attrition are described in this 
flowchart. Treatment delivery is considered adequate if the interventionists’ observance 
level equals 75% of scheduled content to be delivered, as evidenced through 
interventionists’ verification and participants’ verification of treatment objectives. 
 
5.3.10.2 Aim 2  
To determine the intervention feasibility, determinants included acceptability, 
tolerability, and treatment adherence.  
Acceptability was counted as positive and negative expression. Participant 
feedback was documented after each session and reported as a percentage. Tolerability 
was measured as dropout count and reported as a percentage. Treatment adherence was 






5.3.10.3 Exploratory Aim 
To evaluate short term preliminary efficacy outcome measures of symptom 
severity, symptom bother, perceived stress, perceived self-efficacy, and the process 
measure of trajectory of change were analyzed using independent samples t tests, and 
when the assumption was not achieved, Mann-Whitney U tests were employed to 
measure between condition differences. To analyze within condition data paired t tests 
were utilized and in nonparametric instances, the Wilcoxon ranked t test was employed. 
To analyze the exploratory aim process measure, The Patient Global Impression 
of Improvement, linear mixed effects modeling was utilized. These were calculated in 
three models: 1) the entire sample size, irrespective of conditions; 2) split into conditions 




All study protocols, recruitment procedures, measures, and instruments were 
reviewed and approved by the University Institutional Review Board and the Department 
of Human Services Review Board prior to recruitment. Participants were informed of 
expectations of privacy and confidentiality. Every effort was taken to preserve the 
participants’ dignity, respect, and autonomy. 
 
5.3.11.1 Compensation  
A total $100 in gift-card compensation was staggered across the study for all 
participants. Participants who did not complete the study received a prorated amount of 
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compensation. Public transportation passes and parking validations were provided. 
 
5.4 Discussion 
5.4.1 Important Aspects 
This is the first study to ever test feasibility and preliminary efficacy of a 
mindfulness-based stress reduction intervention for urinary urge incontinence (UUI) in 
the older adult population. Additionally, the 2 most marginalized groups in scientific 
research are women and older adults. These 2 populations are underserved when omitted 
from scientific research. As the prevalence of UUI is highest in older adult women, this 
was a crucial population to study. 
 
5.4.2 Expected Outcomes 
As this is a pilot feasibility study, the expected outcomes revolved around the 
feasibility of offering an intensive intervention in this age group.  
 
5.4.3 Problems Anticipated 
One concern included participants locating the study site. The enrollment 
interview took place in the same location as the intervention classes to facilitate 
participant comfort in the logistics of location and parking. A map and instructions for 
navigation and parking were sent to the participant prior to the study, and the participant 
was met at the parking garage and escorted to the building where the enrollment 





This is a feasibility study with a small sample size with potential for  insufficient 
power to determine treatment effectiveness. Based on recommendations in the literature, 
the study did not include one arm without any intervention as a real “control” group.12  
The use of HEP as a comparison condition brought study challenges. Additional 
remuneration is needed when executing a comparison condition. Using HEP may impact 
a larger scale study, perhaps increasing cost and participant obligation. When using 
MBSR, HEP is the gold standard comparison condition. The advantages and 
disadvantages of implementing HEP as a comparison condition are summarized in Table 
2.  
Recruitment in clinical intervention studies is a challenge. This potential 
limitation was mitigated by recruiting across multiple sources and modalities. Having 
postmenopausal status as a requirement targeted recruitment by limiting the potential 
pool of respondents to those within the needed age range.   
 
5.5 Conclusion 
The delineation of a study protocol for testing a specific population with a precise 
condition which uses a complementary treatment is useful for those planning future 
research in similar situations. As this was a pilot feasibility as well as a randomized 
controlled trial, researchers had to plan a rigorous design, a successful recruitment, and 
follow strict protocols throughout the year of research in order to ensure scientific rigor. 
The older adult and female populations, here combined in one group, stand to benefit 
from inclusion in scientific research.  
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Older adult women have the highest incidence of urge urinary incontinence in the 
population. Current treatment practices for this age group remain insufficient and largely 
ineffective. This study sought to determine the research and intervention feasibility of an 
RCT comparing mindfulness-based stress reduction compared with the Health 
Enhancement program in older adult women presenting with urge urinary incontinence. 
A randomized controlled feasibility trial was developed to evaluate 3 
determinants of research feasibility and three determinants of intervention feasibility. 
A feasibility study examining both research and intervention feasibility 
determinants was conducted in a university community. Participants were recruited from 
the university footprint, county senior centers, and community sites.  
Twenty-five postmenopausal women (mean age = 74 years) were randomized into 
a mindfulness-based stress reduction treatment condition or a health enhancement 
comparison condition for an 8-week intervention. Participants remained blinded to 
condition.  
Research feasibility determinants were measured as recruitment, retention, and 
treatment fidelity; intervention feasibility determinants were measured as acceptability, 
tolerability, and treatment adherence.   
Feasibility determinants were recorded and evaluated throughout and at 
completion of the study. All 6 feasibility determinants provided positive results in the 
enrolled population.  
These positive feasibility results warrant the design of a larger scale, multisite 
trial to study the efficacy of mindfulness-based stress reduction in treating urge urinary 
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incontinence in older adult women.  
 
6.2 Introduction 
Recent studies in middle-aged women have shown that a mind-body connection 
may exist for persons with urge urinary incontinence (UUI)*1and that the practice of 
mindfulness may prove helpful in relieving UUI symptoms.1-3 Until now, these results 
have not been translated into research in the predominantly affected population: older 




Urinary incontinence is a pervasive, costly condition most prevalent in older adult 
women. It consists of two subtypes, stress urinary incontinence (SUI) and urge urinary 
incontinence (UUI). SUI is a structural problem, caused by weakened muscles, with 
straightforward and effective treatment generally available. UUI is the more common 
type of urinary incontinence in the older adult female population. 9 Further, it is a more 
complex condition, with a variety of causes, and in many cases it is without a clear cause. 
The medications most often used to treat UUI carry side effects more dangerous for an 
older adult population: falls, dizziness, confusion, and psychosis; these side effects can 
threaten older adult women’s independence.10 Older adult women do not currently have 
                                                 
*1The following abbreviations are used throughout this article:  
HEP: Health Enhancement Program 
MBSR: Mindfulness-Based Stress Reduction 
SUI: Stress Urinary Incontinence 
UUI: Urge Urinary Incontinence 
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sufficient treatment options for UUI.  
 
6.2.2 Purpose 
The feasibility of using mindfulness-based stress reduction (MBSR) in 
comparison to the health enhancement program (HEP)11 in treating older adult women 
with UUI was examined through a randomized controlled feasibility study. Feasibility 
determinants included both research feasibility and intervention feasibility. 
 
6.2.3 Aims 
 Aim 1: To determine the research feasibility of an RCT comparing MBSR and 
HEP in older adult women presenting with UUI, measured by recruitment, 
retention, and treatment fidelity. 
 Aim 2: To determine the intervention feasibility of an RCT comparing MBSR 
and HEP in older adult women presenting with UUI, measured by 
acceptability, tolerability, and treatment adherence. 
 
6.3 Materials and Methods 
Twenty-five postmenopausal women (mean age = 74 years) experiencing at least 
a moderate level of UUI symptoms for at least 3 months prior to screening, were 
recruited into the study through a university health sciences network, a county aging 
services network, and community outreach. Participants were randomized into 1 of 2 
conditions: the treatment condition, MBSR, and the comparison condition, HEP, for the 
intervention. See Section 4.12.14 for the CONSORT flowchart. Participants attended 8 
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weekly sessions of approximately 2 hours each with 1 half-day retreat between the 6th 
and 7th week. The MBSR condition was given the MBSR protocolled standardized 
intervention, focusing on mindfulness. The HEP condition was given the protocolled 
standardized intervention, focusing on functional movement, nutrition, physical activity, 
and music therapy. The sessions also included daily homework practice. Participants 
were given a modest compensation in the form of a gift card. Methods of the study were 
described in detail in an earlier publication.12 
 
6.4 Framework 
Feasibility studies are designed to assess the “potential for successful 
implementation and validity” of larger, subsequent intervention studies.13 According to 
Thabane and colleagues, they are practically essential to conduct.14 The researchers for 
this study utilized a randomized controlled trial approach resulting in the highest rigor of 
scientific studies. Various authors and research groups have delineated necessary 
protocols and best practices for feasibility studies and these were followed in this 
study.14-17 Good clinical practices, which encompass research staff training, informed 
consent procedures, Institutional Review Board (IRB) reporting, and 
monitoring/oversight procedures of both interventionists and participants were adhered to 
throughout. 18 This feasibility study considered and implemented how best to assess 






6.5 Results and Discussion  
The feasibility results of this study are divided into research determinants and 
intervention determinants.  
 
6.5.1 Research Determinants 
The rationale for the selected research feasibility measures, which are defined 
individually below, is drawn from the recommendations of Lancaster, Leon, Thabane, 
Nezu & Nezu, and others.13-15,18,21 These researchers recommended incorporating these 
measures in pilot studies to evaluate the capacity of the research team to properly and 
successfully conduct a larger study.  
 
6.5.1.1 Recruitment 
Several results related to recruitment were discovered. A total of 143 potential 
participants responded to recruitment materials. Sixteen (11%) gave no further contact. 
As such, 127 potential participants were screened over the phone. Eighty-four of those 
(66%) were not eligible. Fourteen of them (11%) were not interested. Twenty-nine (23%) 
scheduled for enrollment. Three of the 29 cancelled before their enrollment appointment 
and did not reschedule. Twenty-six attended their enrollment interview. One failed the 
Montreal Cognitive Assessment (MoCA)22 and was declined enrollment by the 
researcher. The remaining 25 participants, who attended interview and passed the MoCA, 
provided informed consent and enrolled into the study. Recruitment percentage was 
17.48%, as defined by the PI in the most conservative fashion, including those who 
merely responded to an email, expressing no interest. No comparison feasibility data 
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were shared from other MBSR studies; this is unfortunately rarely reported in the 
complementary medicine literature. When accounting for eligibility in recruitment 
calculations, the recruitment percentage was between 43.1-59.52% and serves as a more 
accurate range when examining feasibility. The presentation of a percentage range 
instead of a single percentage is due to an inability to know if the 16 who gave no further 
contact did so because they were ineligible or because they were not interested.  
Consent rate of those who attended the enrollment interview was 100%. A 
consent rate of 100% is a strong indicator of feasibility. This demonstrated that the 
participants were well prepared for the enrollment interview meeting. Providing clear 
recruitment fliers, presentations, and community interactions, combined with efficient 
screening for eligibility and exclusions, and thoroughly reviewing the consent document 
together with the potential participant, allowed them to feel confident in consenting. 
Researchers offered each potential participant the opportunity to bring the consent 
document home, study it further, and discuss with family.  All potential participants 
consented at the enrollment interview.  
Researchers were able to successfully recruit from many of the recruitment sites. 
The sites drawing the most participants were the local county senior centers, followed by 
the university’s Center on Aging participant registry.  
 
6.5.1.2 Retention 
Prior MBSR studies with adults of all ages have reported retention rates of 70-
80%, with those studies having older participants reporting retention rates at the lower 
end of that range.23-25 Of 25 participants enrolled into the two arms of the intervention, 19 
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completed the intervention. This study’s overall retention rate is 73.08%.   
Thirteen participants were randomized into the intervention condition. One was 
unable to participate due to an unexpected and urgent move out of state. Another began 
the study with complications from cataract surgery and was hospitalized with pneumonia 
the second week of class. She was ill for over a month and did not return to the study. As 
such, 11 of the 13 enrolled and randomized into the intervention arm finished the study. 
This is a retention rate of 84.61%.  
Twelve were randomized into the comparison condition. One dropped out before 
the study began, citing a withdrawal of her transportation option. Two dropped out due to 
volunteer and career demands (1 left on a volunteer mission; another was given 
additional responsibility at work and could no longer attend the daytime intervention). 
One deemed the intervention not helpful and stopped attending classes. Thus, 8 of the 12 
in the comparison condition finished the intervention. This is a retention rate of 66.67%.  
While participants remained blinded to condition throughout the study, the lower 
retention rate in the comparison condition is perhaps not surprising. While therapeutic in 
its own right, HEP remains an active control. It was created as a comparison condition to 
MBSR studies, matching MBSR in positive expectations, requiring an equivalent 
commitment from the participant and providing a plausible alternative for success.26  
Participants in both conditions showed mild to moderate surprise that their 
interventions were not treatment as usual. Unsolicited comments from at least one 
participant in each condition stated that they wondered if they were in the control 
condition, as they were not learning or practicing typical treatments for urinary 
incontinence. This perplexity continued for the first several weeks of class until the 
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participants settled into their coursework. One participant commented during week 3 “I 
thought I’d be doing Kegels. This is good.” 
 
6.5.1.3 Treatment Fidelity 
Determination of treatment fidelity is imperative to both external and internal 
validity of outcomes observed.27 This study measured treatment fidelity across 5 
recognized standard of science elements as suggested by Bellg and colleagues: study 
design, provider training, enactment of treatment skills, treatment delivery, and treatment 
receipt.28 
 
6.5.1.3.1 Study Design 
Treatment fidelity in study design was ensured through blinding participants to 
condition and applying treatment doses evenly, both within and across conditions. So as 
to minimize confounding, the treatment and comparison conditions were held on separate 
days of the week and neither participants nor interventionists ever met or interacted with 
one another.  
 
6.5.1.3.2 Provider Training  
Treatment fidelity in provider training was established by the PI ensuring that 
MBSR and HEP interventionists were certified in their respective fields. Additionally, it 
was verified that each interventionist held appropriate and current certifications. The PI 
also met with the interventionists prior to the beginning of the intervention to confirm 
each was trained to follow their respective standardized curricula throughout the 
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intervention period.   
 
6.5.1.3.3 Enactment of Treatment Skills 
Treatment fidelity in enactment of treatment skills was met by substantiating that 
interventionists had processes in place that allowed them to “monitor and improve the 
ability of [participants] to perform treatment-related behavioral skills.”28 These processes 
included monitoring and providing feedback in class practice sessions as well as 
providing further homework practice materials for the participants throughout the week.  
 
6.5.1.3.4 Treatment Delivery  
Treatment fidelity in treatment delivery addresses the adherence of the 
interventionist to the content and protocols of their curricula. This was measured from 2 
perspectives, verified with both the interventionists and the participants. The PI met with 
each interventionist after each session to determine if the content of the intervention had 
been delivered. The MBSR interventionist verified content delivery at 100% across the 9 
sessions. Two sessions were reported at 80%; however, that material was presented in 
subsequent courses. This is a per-class average of 95.55%. The HEP interventionist also 
confirmed 100% treatment delivery across all sessions. One session was reported at 75% 
and another at 90% and again the remainder of the material was delivered in subsequent 
sessions. This is a per-class average of 96.11% for the HEP intervention. Again, both 
interventionists reported overall treatment delivery of 100% across the full course.  
Treatment delivery from the perspective of the participant was measured through 
a checklist given to the participant at the end of the intervention. Participants were asked 
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to mark the items that were taught throughout the course of the intervention. Each brief 
checklist (for both MBSR and HEP) contained 16 items and participants averaged 93% 
(14.9/16) using an intent-to-treat analysis. This is well above a 75% rate (12/16) which is 
considered as the standard of treatment delivery.15  
A final feasibility measure of treatment delivery within treatment fidelity was to 
corroborate that each interventionist had a plan in place in case of absence. Each 
interventionist had 1 day that they were unable to teach and after discussion with the PI, 
each chose to resolve it differently. The MBSR teacher needed to be absent in Week 8, 
and she arranged for a trained and certified substitute. The HEP interventionist needed to 
be absent in Week 7, and she rescheduled the date of the course to 1 day earlier. All 
participants in the HEP comparison condition were willing to arrange their schedules to 
come at this alternate date and time. This flexibility was displayed by all participants in 
the condition.   
 
6.5.1.3.5 Treatment Receipt 
Treatment fidelity in treatment receipt occurred with interventionists asking 
questions of and discussing with the participants the content of each course. It was 
evaluated by having interventionists collect homework practice, logs, and charts and 
conferring with participants both during and after classes. In addition, interventionists 
made themselves available to participants between classes via email and phone.  
The MBSR study condition reported 95% attendance and 96% homework practice 
in attendees. The HEP study condition reported 93% attendance and 93% homework 
practice in attendees. Absences were marked excused/unexcused; all absences in both 
168 
 
conditions during the study were excused, as they were due to illness, travel, hardships, 
or religious obligations. In most instances, the participant called before the date to let the 
interventionist know they would be absent and the reason for the absence. A participant 
who was absent would often submit their homework the week they returned. Consistent 
with the adult learning environment, homework was not “graded” but marked turned in/ 
not turned in. 
Each assessment of the 5 types of treatment fidelity evidenced successful 
outcomes.  
 
6.5.2 Intervention Determinants 
The rationale for the selected intervention feasibility measures, listed individually 
below, is drawn from the scientific literature regarding feasibility studies.21,29-32  
 
6.5.2.1 Acceptability 
Lancaster and colleagues recommend determining acceptability in a pilot study.21 
Acceptability in the study was measured by randomly selecting two participants after 
each class each week and asking them the open-ended question, “How did it go today?” 
This resulted in a total of 32 unstructured responses. While this is not a full representation 
of every participant every week, collecting that amount of information from each 
participant would have resulted in a participant burden that researchers deemed too high 
during the study design phase.  
In addition to being too burdensome to participants to be asked to comment each 
week, researchers were concerned that this amount of feedback response could cause a 
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Hawthorne effect in the data. This is an unintended consequence of the participant 
changing their interaction as a result of the researcher’s involvement.33 In this case, the 
concern was that the participant might subconsciously alter their responses to elicit 
interviewer “approval.” Thus, 2 participants were randomized and interviewed 
immediately after each class session.  
Each of these responses was coded as positive or negative by the PI. Interrater 
reliability was achieved by having a second member of the research team independently 
code the responses as well. No discrepancies were noted between ratings and they were 
accepted as correct. All 32 responses were positive. This is an acceptability rate of 100% 
for all participants, as well as participants per condition.  
This acceptability result of 100% is a strong indicator that the participants were 
fully accepting of an MBSR course as well as an HEP course to treat their UUI. It is 
postulated that this high of an acceptability percentage was influenced by hiring 
instructors with the highest levels of expertise and the correct certifications available. 
Participant comments on the MBSR instructor included, “I came and just thought the first 
time I did it, let it keep going going going going [sic] - it couldn't have been better - it 
was perfect. [Name]’s sure a great teacher - at least she sure connected with me.” 
Participant comments on the HEP instructor included, “[Name] is always well organized 
- she introduces every opportunity and guides you comfortably - she is always reframing 
so we can all participate; I've never seen anyone not participate. She is so helpful and 
willing to interact personally.”   
The older adult women in the study often commented on the strong sense of 
community and pleasant group dynamics that developed in each intervention. This 
170 
 
appeared to be a meaningful and satisfying area for them. This is aligned with Lamb and 
Brady’s findings that a development of community is important to older adult learners.34 
One woman stated after week 5, “See [Name]? She and I have lived on the same street 
for 3 years and never said a word to each other. And now we’re friends!” 
 
6.5.2.2 Tolerability  
Tolerability was determined from number of dropouts due to stated distress from, 
or dislike of, either intervention experience. In this case, a greater number of such 
dropouts is associated with reduced tolerability. This is a separate measure from 
participants who need to withdraw due to a family emergency or a medical illness.16,32 
All participants who withdrew were asked a single question, “Help me understand what 
made this challenging?” Of the original 25 participants, 19 completed the study. All 
causes for participant dropout in this study are explained in section 6.5.1.2 above, 
Retention. Only one of these dropouts was due to dislike of the intervention experience. 
She stated, “When it didn’t seem to help I decided I wouldn’t keep coming.” Given these 
data, tolerability for the study was calculated at 96%. The only participant who dropped 
due to dislike was in the HEP comparison condition. Tolerability for MBSR was 100%, 
and tolerability for HEP was 91.67%.  
 
6.5.2.3 Treatment Adherence 
Treatment adherence was measured in two main categories at each session: 
attendance and homework completion. Results are reported below for those 19 
participants who completed the intervention. These were tallied by the interventionist and 
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the PI, respectively. Attendance was recorded during all 9 sessions of the course, weeks 1 
through 8 plus the retreat halfway between weeks 6 and 7. Attendance for the MBSR 
condition averaged 95.96% and attendance for the HEP condition averaged 97.22%. 
Participants submitted each week’s practice logs/homework to evidence treatment 
adherence. These were recorded as turned in/not turned in. Homework was recorded for 7 
sessions of the course, as none was collected during week 1 or the retreat day. Homework 
submission for the MBSR condition averaged 88.43%. Homework submission for the 
HEP condition averaged 89.57%.  
Participants were assured at the beginning of the intervention and throughout the 
course that homework participation was voluntary. The high rates of practice 
logs/homework indicate an eagerness by the participants to participate fully in the 
intervention experience and are seemingly equal across conditions.   
 
6.6 Conclusion 
The results of this study are encouraging for the development of future research 
studies. Recruitment, retention, treatment fidelity, acceptability, tolerability, and 
treatment adherence were measured and evaluated as successful. This is a wide scope to 
examine, and all six feasibility determinants were successfully met. 
 
6.6.1 Limitations 
This study recruited participants from one county within one state. As such, it is 
with caution that results are considered generalizable.  
Qualitative responses were given by participants in this study, and these responses 
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were converted for simplicity in evaluating acceptability quantitatively for this 
manuscript. It is the opinion of the authors that the qualitative data will also contribute to 
implications and future research. Many unsolicited comments from participants were also 
noted and dated throughout the study and these will be considered for qualitative analysis 
as well. As such, a forthcoming qualitative paper will be submitted for publication upon 
successive qualitative analysis of these statements.   
 
6.6.2 Implications for Future Research  
The main aims of this study were to test both research and intervention feasibility 
determinants in the specific older adult female population with moderate to severe urge 
urinary incontinence. The successful feasibility results of this study help researchers 
prepare to design a larger scale trial. Increases in the older adult population and the cost 
of treating UUI makes this research all the timelier and are factors that spur future 
research. A multisite trial examining efficacy of treatment can now be designed, as 
concerns regarding feasibility in this specific population are alleviated.  
Older adult women deserve better options for treating this condition. These 
findings point to the need for future research to determine whether mindfulness-based 
stress reduction can provide this needed treatment.  
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The results of the two primary feasibility analyses were addressed in the prior 
feasibility results article. The results of the final, exploratory aim for this trial are 
addressed in this chapter. 
 Exploratory aim: To evaluate the short-term preliminary efficacy of MBSR for 
treatment of UUI in older adult women, in comparison to HEP, including 
symptom severity, symptom bother, perceived stress, perceived self-efficacy, and 
the rate and trajectory of change. 
The preliminary efficacy measures included both outcome and process measures 
for each treatment condition, as outlined in Section 7.6.1, Table 6. Four outcome 
measures (Incontinence Severity Index, Overactive Bladder Questionnaire Short Form, 
Perceived Stress Scale, and Geriatric Self Efficacy—Urinary Incontinence) were 
collected at enrollment and administered again at completion of the intervention, to 
evaluate severity, bother, perceived stress, and perceived self-efficacy, respectively. 
Additionally, one process measure (Patient Global Impression of Improvement) was 
administered after each class session, for a total of nine times, to evaluate the trajectory 
and rate of change.  
All data were analyzed using intent-to-treat analysis (ITT). This protocol entails 
all data being incorporated when calculating findings, including data from those who 
discontinued the study (n = 6, 24%). This serves as a basic solution to noncompletion and 
missing outcomes in randomized controlled trials (Gupta, 2011). In this study, all 
participants who withdrew from the study (with the exception of one participant who 
suddenly needed to move from the state), returned to complete the outcome and process 
measures at study completion (n = 5, 20%). As such, all data analysis is calculated with 
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all data available, including the data from those participants who withdrew. While this 
produces more conservative results, it is best practice to account for overall efficacy in a 
randomized controlled trial, as it acknowledges that clinical practice would encounter 
deviations from protocol as well as noncompletion (Heritier, Gebski, & Keech, 2003).   
 
7.1 Demographics 
Demographic measures were collected at enrollment. The demographic variables 
were divided into continuous and categorical values and frequency statistics were 
calculated (7.6.2, Tables 7 and 8). These were compared between treatment conditions to 
determine whether or not participants in each treatment condition were statistically 
similar to one another (7.6.3, Tables 9 and 10). Values such as age, BMI, length of UUI, 
number of deliveries, and age of menopause onset did not show significant differences. 
Specifics regarding these and other values, including range and means, are explained in 
detail below. 
 
7.1.1 Comparison of Mean Ranks 
No significant differences were observed in the mean ranks between the MBSR 
and HEP conditions at p < .05.  
 
7.1.1.1 Age  
The mean of the ranks for the MBSR condition was 12.85, while the mean of the 
ranks of the HEP condition was 13.17 (U = 76.00, p = .91). The mean age in the MBSR 
condition was 73.92 (SD = 7.22) with a range of 66-87, while the mean age in the HEP 
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condition was 73.08 (SD = 9.93) with a range of 56-87). There were no significant 
differences at p < .05. 
 
7.1.1.2 BMI  
The mean of the ranks for the MBSR condition was 11.00, while the mean of the 
ranks of the HEP condition was 15.17 (U = 52.00, p = .16). The mean BMI in the MBSR 
condition was 25.58 (SD = 4.57), with a range of 18.37 – 32.53, while the mean BMI in 
the HEP condition was 31.31 (SD = 11.43) with a range of 20.32 - 61.08. There were no 
significant differences at p < .05. 
 
7.1.1.3 Number of Deliveries  
The mean of the ranks for the MBSR condition was 12.42, while the mean of the 
ranks of the HEP condition was 13.63 (U = 70.50, p = .68). The mean number of 
deliveries in the MBSR condition was 3.46 (SD = 3.05) with a range of 0 - 12, while the 
mean number of deliveries in the HEP condition was 3.42 (SD = 2.02) with a range of 0-
6. There were no significant differences at p < .05. 
 
7.1.1.4 Age of Onset of Menopause  
The mean of the ranks for the MBSR condition was 12.50, while the mean of the 
ranks of the HEP condition was 9.00 (U = 36.00, p = .20). The mean age of onset of 
menopause in the MBSR condition was 54.42 (SD = 7.79) with a range of 40 - 60, while 
the mean age of onset of menopause in the HEP condition was 48.33 (SD = 4.00) with a 
range of 44 - 56. There were no significant differences at p < .05. 
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7.1.1.5 Length of Urge Incontinence (Years)  
The mean of the ranks for the MBSR condition was 12.85, while the mean of the 
ranks of the HEP condition was 13.17 (U = 76.00, p = .91). The mean number of years 
with urge incontinence in the MBSR condition was 9.56 (SD = 13.16) with a range of 4 
months to 50 years, while the mean number of years with urge incontinence in the HEP 
condition was 6.25 (SD = 3.84) with a range of 1 – 13 years. There were no significant 
differences at p < .05. 
 
7.1.1.6 Number of Prescription Medications  
The mean of the ranks for the MBSR condition was 10.23, while the mean of the 
ranks of the HEP condition was 12.77 (U = 46.50, p = .35). The mean number of 
prescription medications used in the MBSR condition was 3.09 (SD = 2.26) with a range 
of 1 – 8, while the mean number of prescription medications in the HEP condition was 
3.64 (SD = 1.80) with a range of 1 - 7. There were no significant differences at p < .05. 
 
7.1.1.7 Daily Caffeine Use (Servings)  
The mean of the ranks for the MBSR condition was 11.96, while the mean of the 
ranks of the HEP condition was 13.04 (U = 65.50, p = .70). The MBSR condition 
reported consuming a mean of 1.17 (SD = 1.27) servings of caffeine daily with a range of 
0 - 4, while the HEP condition reported 1.50 (SD = 1.62) servings of caffeine daily with a 





7.1.1.8 Types of Physical Health Conditions Reported  
The mean of the ranks for the MBSR condition was 10.85, while the mean of the 
ranks of the HEP condition was 13.50 (U = 50.00, p = .29). The MBSR condition 
reported a mean of .38 (SD = .65) of the 4 types of physical health conditions (high blood 
pressure, diabetes, cancer, heart problems), while the HEP condition reported a mean of 
.90 (SD = 1.20) of the health conditions. There were no significant differences at p < .05. 
 
7.1.1.9 Types of Mental Health Conditions Reported  
The mean of the ranks for the MBSR condition was 11.88, while the mean of the 
ranks of the HEP condition was 12.15 (U = 63.50, p = .85). The MBSR condition 
reported a mean of .08 (SD = .28) of the 2 types of mental health conditions (anxiety, 
depression), while the HEP condition reported a mean of .10 (SD = .32) of the mental 
health conditions. There were no significant differences at p < .05. 
 
7.1.1.10 Types of Prescription Medications Reported  
The mean of the ranks for the MBSR condition was 13.19, while the mean of the 
ranks of the HEP condition was 12.79 (U = 75.50, p = .88). The MBSR condition 
reported a mean usage of .62 (SD = .65) of the 4 types of prescription medications 
(antidepressants/anxiolytics, sleep medications, pain medications, beta-blockers), while 
the HEP condition reported a mean of .58 (SD = .67) of the types of prescription 





7.2 Outcome Measures 
7.2.1 Reliability  
Statistical analysis on outcome measures began with reliability calculations of 
each scale. The Cronbach’s α score was calculated for each outcome measure. 
Cronbach’s α values are accepted as 0.5 - <0.6 poor, 0.6 - <0.7 questionable, .0.7 - <0.8 
acceptable, 0.8 - <.09 good, and >= 0.90 excellent (Cronbach, 1951; Taber, 2016). The 
Incontinence Severity Index showed below poor reliability in this sample, with a 
Cronbach’s α = 0.46. The ISI contains two questions. The length of the test affects the α 
value: According to several authors, if the length of the test is too short, the α value is 
reduced (Streiner, 2003; Tavakol & Dennick, 2011). Additionally, as this was mainly a 
feasibility study, the sample size is quite small which can also affect the α value (Button 
et al., 2013). 
The Overactive Bladder Questionnaire (OAB-q) contains 19 questions, with α = 
.88 in this sample. As explained in Chapter 4, while the scale is only validated as a whole 
to measure bother, it contains two parts, the first measuring severity and the second 
measuring bother (Pfizer representative Sheryl, personal communication, August 26, 
2016). As such, Cronbach’s α values for part 1 and part 2 of the OAB-q were also 
calculated, with Cronbach’s α scores equaling α = .70 and α = .87, respectively. The 
overall and the Part 2 reliability coefficients are interpreted as strong, while the Part 1 
coefficient is interpreted as moderate. 
The Perceived Stress Scale (PSS) has 10 items and an α = .85 in this sample, 
indicating strong reliability. The Geriatric Self-Efficacy Urinary Incontinence Scale 
Cronbach’s α remained the same value, α = .91, testing with the original 12 questions and 
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with the added adapted question totaling 13 questions, both indicating strong reliability. 
Additionally, the same α score in the original GSE-UI (12 questions) and the adapted 
GSE-UI (13 questions) indicates that the added question does not provide a stronger 
reliability with its inclusion. 
 
7.2.2 Assumptions of Normality 
Prior to analyzing each test, assumptions of normality were examined (see 
Chapter 4). The Kolmogorov-Smirnov test was prioritized over the Shapiro-Wilk test for 
evaluating assumptions of normality, as the Shapiro-Wilk is the stricter of the tests and a 
less appropriate fit for a small feasibility study. Additional ways of testing normality 
assumptions were analyzed for each data set, including the Fisher’s skewness coefficient, 
the kurtosis coefficient, the histogram, and the Q-Q plot. These are presented in Section 
7.6.5. While there is some conflict in normality outcomes, the majority of tests support 
normality.   
 
7.3 Key Findings 
7.3.1 Overall Intervention Results 
All outcome measures were administered before and after the intervention in both 
treatment conditions. Data were analyzed to uncover whether participants saw 
improvement. Participants saw significant improvement in all four outcome measures: 
Severity, bother, perceived stress, and perceived self-efficacy. A paired t test was 
conducted to compare the overall pre- and postdifferences for ISI scores. There was a 
significant decrease in ISI scores at posttest (M = 5.08, SD = 3.5) compared to pretest (M 
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= 8.00, SD = 3.02; t = 4.32, df = 23, p = .00). A paired t test to compare pre-and post- 
OAB-q scores showed a similar decrease in OAB-q scores from pre- (M = 66.79, SD = 
17.84) to posttest (M = 44.88, SD = 19.59, t = 5.55, df = 23, p = .00). Paired t tests also 
showed a significant decrease in PSS scores at posttest (M = 9.79, SD = 8.09) compared 
with pretest PSS scores (M = 12.29, SD = 7.07, t = 2.34, p = .01), and a significant 
increase in GSE-UI scores (pretest: M = 65.83, SD = 28.84; posttest: M = 77.13, SD = 
35.16, t = -2.26, df = 23, p = .02).  
The nonparametric test, Wilcoxon Signed-Ranks, was also conducted to 
determine if the pre- and posttest scores for the Likert scale ISI, OAB-q, PSS, and GSE-
UI questions showed participant improvement. The medians for the pretest and posttest 
ISI scores were 8.00 and 4.00, respectively. We found a significant effect for ISI in favor 
of lower posttest scores (the mean ranks for positive and negative ranks were 5.50 and 
10.00 respectively; Z = -3.27, p = .00). The medians for the pretest and posttest OAB-q 
scores were 65.00 and 40.50, respectively. There was a significant effect for OAB-q (the 
mean ranks for the positive and negative ranks were 7.50 and 12.20, respectively; Z = -
3.97, p = .00). Similarly, there was a significant effect for PSS in favor of lower PSS 
scores at posttest; the mean rank for negative ranks was 15.73 and 7.15 for positive ranks, 
Z = -2.03, p = .02. The median pretest score for PSS was 13.00 and the median posttest 
score was 7.50. There was a significant effect for GSE-UI in favor of higher posttest 
GSE-UI scores than pretest scores. The median pretest GSE-UI score was 67.00 and the 
median posttest score was 79.00. The mean rank for the negative ranks was 10.06 while 
the mean rank for the positive ranks were 13.72, Z = -1.99, p = <.05. These significant 
changes are reported in Section 7.6.5, Table 12.  
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7.3.2 Within-Condition Results 
I also examined if significant within-condition improvement occurred (i.e., if the 
participants in the MBSR condition and/or the HEP significantly improved on outcome 
measures from enrollment to completion). Within- condition comparisons were analyzed 
with paired samples t tests and their nonparametric version, the Wilcoxon signed rank 
test. 
Paired t tests were conducted to evaluate whether the pre- and postscores showed 
improvement in the MBSR and HEP groups, respectively.  
In the MBSR group, there was a significant decrease in ISI scores at posttest (M = 
4.08, SD = 3.45) compared to pretest (M = 7.00, SD = 3.19; t = 2.80, df = 11, p = .01). A 
paired t test to compare pre-and post-OAB-q scores showed a similar decrease in OAB-q 
scores from pre- (M = 64.25, SD = 21.16) to posttest (M = 38.83, SD = 17.73, t = 5.12, df 
= 11, p = .00). Paired t tests also showed a significant decrease in PSS scores at posttest 
(M = 7.92, SD = 7.29) compared with pretest PSS scores (M = 11,00, SD = 8.74, t = 1.96, 
p = .04), and a significant increase in GSE-UI scores (pretest: M = 71.83, SD = 34.09; 
posttest: M = 88.33, SD = 36.37, t = -2.60, df = 11, p = .01).  
In the HEP group, there was a significant decrease in ISI scores at posttest (M = 
6.08, SD = 3.45) compared to pretest (M = 9.00, SD = 2.59; t = 3.21, df = 11, p = .00). A 
paired t test to compare pre- and post-OAB-q scores showed a similar decrease in OAB-q 
scores from pre- (M = 69.33, SD = 14.27) to posttest (M = 50.92, SD = 20.21, t = 2.93, df 
= 11, p = .01). Paired t tests did not show a significant decrease in PSS scores at posttest 
(M = 11.67, SD = 8.72) compared with pretest PSS scores (M = 13,58, SD = 7.49, t = 
1.28, p = .11). The increase in GSE-UI scores (pretest: M = 59.83, SD = 22.33; posttest: 
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M = 65.92, SD = 31.43, t = -.793, df = 11, p = .22) did not reach significance.  
The nonparametric test, Wilcoxon Signed-Ranks, was also conducted to examine 
if the pre- and posttest scores for the Likert-type scale ISI, OAB-q, PSS, and GSE-UI 
questions showed participant improvement. 
In the MBSR group, the medians for the pretest and posttest ISI scores were 6.00 
and 2.50, respectively. We found a significant effect for ISI in favor of lower posttest 
scores (the mean ranks for positive and negative ranks were 4.00 and 5.13, respectively; 
Z = -2.23, p = .01). The medians for the pretest and posttest OAB-q scores were 64.00 
and 34.50, respectively. There was a significant effect for OAB-q (the mean ranks for the 
positive and negative ranks were .00 and 6.50, respectively; Z = -3.06, p = .00). There 
was no significant effect for PSS in favor of lower PSS scores at posttest; the mean rank 
for negative ranks was 9.00 and 3.50 for positive ranks, Z = -1.08, p = .14. The median 
pretest score for PSS was 13.00 and the median posttest score was 5.50. There was a 
significant effect for GSE-UI in favor of higher posttest GSE-UI scores than pretest 
scores. The median pretest GSE-UI score was 84.00 and the median posttest score was 
102.50. The mean rank for the negative ranks was 9.00 while the mean rank for the 
positive ranks were 6.27, Z = -2.35, p = <.05. 
In the HEP group, the medians for the pretest and posttest ISI scores were 8.50 
and 7.00, respectively. We found a significant effect for ISI in favor of lower posttest 
scores (the mean ranks for positive and negative ranks were 2.00 and 5.38, respectively; 
Z = -2.44, p = .01). The medians for the pretest and posttest OAB-q scores were 66.50 
and 47.50, respectively. There was a significant effect for OAB-q (the mean ranks for the 
positive and negative ranks were 4.00 and 6.20, respectively; Z = -2.58, p = .01). There 
188 
 
was no significant effect for PSS in favor of lower PSS scores at posttest; the mean rank 
for negative ranks was 7.13 and 5.25 for positive ranks, Z = -1.42, p = .08. The median 
pretest score for PSS was 11.00 and the median posttest score was 9.50. There was no 
significant effect for GSE-UI in favor of higher posttest GSE-UI scores than pretest 
scores. The median pretest GSE-UI score was 61.00 and the median posttest score was 
63.00. The mean rank for the negative ranks was 4.64 while the mean rank for the 
positive ranks were 9.10, Z = -.51, p = .31. 
The paired t tests and the Wilcoxon signed ranks test produced statistically similar 
results, with the exception of the MBSR PSS results (Section 7.6.6 Tables 13, 14). 
 
7.3.3 Between-Condition Results 
Each outcome measure corresponds to one of four research questions related to 
the exploratory aim. All research questions were analyzed using both independent t tests 
and their nonparametric equivalent, Mann Whitney U tests. These results are summarized 
in Section 7.6.8, Tables 15, 16. These results were obtained using intent-to-treat analysis. 
Below is a between-condition comparison of the conditions congruent with the research 
questions.  
 
7.3.3.1 RQ 1 Does MBSR Reduce UUI Severity in Older Adult Women 
 as Compared to HEP?  
Severity was analyzed by the Incontinence Severity Index (ISI) and informally 
through the OAB-q SF Part 1 scores. Independent samples t tests and Mann Whitney U 
tests were conducted to examine if MBSR reduced UUI severity in older adult women 
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compared to HEP for these Likert-type scale questions. The mean scores for participants 
in the MBSR condition and the HEP condition at posttest were 4.08 (SD = 3.45) and 6.08 
(SD = 3.45), respectively. The independent samples t test indicated that there were no 
significant differences in posttest ISI scores (t = -1.42, df = 22, p = .07). The Mann-
Whitney U test confirmed the nonsignificant finding (the mean rank for the MBSR 
condition was 10.38, while the mean rank for the HEP condition was 14.63; U = 46.50, Z 
= -1.49, p =.07). No differences were found between groups when measuring severity 
with the ISI.  
Means for the OAB-q Part 1 scores among participants in the MBSR and HEP 
condition were 23.00 (SD = 11.46) and 30.92 (SD = 14.99), respectively. While no 
significant differences in OAB-q part 1 scores were found between groups with the 
independent samples t test (t = -1.45, df = 22, p = .08), the Mann-Whitney U test results 
showed statistical significance (the mean rank for the MBSR condition was 9.71, while 
the mean rank for the HEP condition was 15.29; U = 38.50, Z = -1.94, p = .03). The 
nonparametric test showed differences between conditions.  
 
7.3.3.2 RQ 2: Does MBSR Reduce UUI Bother in Older Adult Women 
 as Compared to HEP?   
Bother was analyzed by the overall and Part 2 (HRQL) scores of the OAB-q SF. 
Independent samples t tests and Mann Whitney U tests were conducted to evaluate the 
difference between conditions at posttest for these Likert-type scale questions. Mean 
scores for the overall OAB-q scores were 38.83 (SD = 17.73) and 50.92 (SD = 20.21) for 
the MBSR and HEP conditions, respectively. The independent samples t test found that 
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the differences between conditions was not significant (t = -1.56, df = 22, p = .07) at 
posttest. The Mann-Whitney U test showed significant differences between groups at 
posttest (the mean rank for the MBSR condition was 9.75, while the mean rank for the 
HEP condition was 15.25; U = 39.00, Z = -1.91, p = .03). The parametric test showed no 
differences while the nonparametric tests showed a difference. 
Similarly, OAB-q Part 2 scores which measure bother specifically, were lower in 
the MBSR condition (M = 23.00, SD = 11.46) compared to HEP (M = 30.92, SD = 14.99) 
at posttest. The results of the independent samples t test indicated that differences in 
OAB-q Part 2 scores were not significant (t = -1.45, df = 22, p = .08), although the results 
from the Mann-Whitney U test showed statistical significance (the mean rank for the 
MBSR condition was 9.71, while the mean rank for the HEP condition was 15.29; U = 
38.50, Z = -1.94, p = .03). Again, the parametric test showed no differences while the 
nonparametric tests showed a difference. 
 
7.3.3.3 RQ 3: Does MBSR Reduce Older Adult Women’s Perceived Stress  
in Older Adult Women as Compared to HEP?  
Perceived stress was analyzed by the Perceived Stress Scale (PSS) scores. While 
PSS means were lower for participants in the MBSR condition (M = 7.92, SD = 7.29) 
compared to participants in the HEP condition (M = 11.67, SD = 8.72) at posttest, no 
significant difference was found between the MBSR and HEP conditions using an 
independent samples t test (t = -1.14, df = 22, p = .14) and Mann-Whitney U test (the 
mean rank for the MBSR condition was 10.63, while the mean rank for the HEP 
condition was 14.38; U = 49.50, Z = -1.30, p = .10). This indicates that there was no 
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difference between groups when measuring perceived stress.  
 
7.3.3.4 RQ 4: Does MBSR Increase Older Adult Women’s Self-Efficacy  
Surrounding Self-Management of UUI Symptoms as Compared to HEP?  
Perceived self-efficacy was analyzed by the adapted Geriatric Self-Efficacy Index 
for Urinary Incontinence (GSE-UI). While mean scores were higher for participants in 
the MBSR condition (M = 88.33, SD = 36.37) compared to the HEP condition (M = 
65.92, SD = 31.43), an independent samples t test and Mann-Whitney U test were 
conducted to assess if these differences were significant. The t test found no significant 
differences between conditions at posttest for GSE-UI, t = 1.62, df = 22, p = .06. The 
Mann-Whitney U test found no significant differences at posttest as well (the mean rank 
for the MBSR condition was 14.75, while the mean rank for the HEP condition was 
10.25; U = 45.00, Z = -1.56, p = .06). This indicates that there was no difference between 
groups when measuring perceived self-efficacy.  
 
7.3.4 Process Measure  
7.3.4.1 RQ 5: What is the Rate and Trajectory of Change, as Reported by 
Participants in Each Condition? 
The process measure, used to evaluate rate and trajectory of change in the study, 
is the Patient Global Impression of Improvement (PGI-I). It is difficult to 
psychometrically evaluate a single Likert-type item, such as the PGI-I, as conventional 
reliability methods (e.g., Cronbach’s alpha) are not applicable (Gliem & Gliem, 2003); 
however, the measure is ubiquitously used and has demonstrated desirable validity and 
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reliability characteristics (Marshall, 2007).  
The PGI-I data were analyzed using a linear mixed effects model. For this 
modeling, the SPSS data were converted into Excel files and exported into STATA. 
Three models were explored. Model 1 evaluated the overall data from the entire sample 
size without considering differences by randomized treatment (e.g., MBSR versus HEP). 
This model showed statistically significant increase in PGI-I across the weeks of the 
intervention (b = 0.17; p < 0.001). Model 2 is the preferred model of the three considered 
and specifies the effect of randomized treatment, which shows a statistically significant 
positive effect for the MBSR condition versus the HEP condition (b = 0.48; p < 0.05). In 
Model 2, the time trajectory remains highly significant (b = 0.17; p = <0.001), as in 
Model 1. Model 3 specifies an interaction between time and experimental condition, as 
well as main effect for these two terms. In Model 3, the coefficients show non-
statistically significant effect of the time*treatment interaction term. While the interaction 
was statistically nonsignificant, it was in the predicted direction, suggesting a nominally 
higher slope for the MBSR condition. It is worth noting that the model is weakly powered 
to detect interaction effects (Yalcin & Bump, 2003), thus larger sample sizes will be 
necessary to follow up on the suggestive interaction result. Finally, including the 
interaction effect fails to improve model fit as assessed by likelihood ratio test (chi2 = 
1.39; p >0.05); thus, Model 2 is the preferred model (Section 7.6.7). This indicates that 






7.3.5 Effect Size and Power Analysis 
While researchers often only report p values to indicate statistical significance, 
this can be a limitation. Further, effect sizes are typically not reported unless the p values 
are significant. P values depend to some degree on standard error; a larger sample size 
decreases standard error and lowers the p value (Altman & Bland, 2005). In fact, a 
statistically significant p value, according to Tomczak and Tomczak, sometimes “mainly 
indicates that a huge sample size was used” (2014, p. 20; Bradley & Brand, 2013; 
Sullivan & Feinn, 2012). P values as such do not indicate the strength of the relationship 
between the variables (Fritz, Morris, & Richler, 2012). Thus, Tomczak and Tomczak 
(2014) recommend reporting the effect size estimates alongside null findings.  
Effect sizes were calculated for between-condition results from the independent 
samples t tests, and were reported as Cohen’s d. Cohen’s d scores are accepted as 0.2 = 
weak, 0.5 = moderate, and 0.8 indicating strong reliability (Ellis, 2010). Three of the four 
outcome measures (ISI, OAB-q, and GSE-UI) were found to have moderate effect sizes 
(ISI ES = .58, power = 27%; OAB-q ES = .64, power = 32%; GSE-UI ES = .66, power = 
34%; Table 15). The fourth, PSS, was found to have low effect size, PSS ES = .47, power 
= 20%. Since this is a pilot study, we also examined post-hoc power analyses. Power 
analyses were calculated and were low, as expected, due to a small sample size (Section 
7.6.8 Table 15 and 16). 
Effect sizes were also calculated for results from the Mann-Whitney U tests and r 
coefficients were reported. ISI, PSS, and GSE-UI showed weak effects while OAB-q 
showed a strong effect (ISI ES = .32, OAB-q ES = .73, PSS ES = .34, GSE-UI ES = .31). 
Effect sizes for the Mann-Whitney U tests are reported in Table 16.  
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7.3.6 Follow-Up Wave 
The data collection from the follow-up wave of this randomized controlled trial, 
conducted during November and December of 2017, will be analyzed in January 2018. 
These data are outside the scope of the dissertation. The data from this additional wave, 
examining whether improvement in each condition was sustained, may strengthen the 
analysis of dissertation findings reported here.  
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7.6 Supplementary Information 
7.6.1 Outcome and Process Measures 
Table 6 Outcome and Process Measures 
Preliminary Efficacy Instrument Administered 
Symptom Severity (Outcome 
Measure) 
Incontinence Severity Index 
Part 1 of Overactive Bladder 
Questionnaire Short Form 
(Q1-6) 
At baseline and at study 
completion, by participant 
 




Questionnaire Short Form 
Overall and Part 2 (HRQL) 
specifically 
 
At baseline and at study 
completion, by participant 
 
Perceived Stress (Outcome 
Measure) 
 
Perceived Stress Scale 
 
At baseline and at study 
completion, by participant 
 




Index of Urinary 
Incontinence 
 
At baseline and at study 
completion, by participant 
 
Rate and Trajectory of Change 
(Process Measure) 
 
Patient Global Impression 
of Improvement (PGI-I) 
After each session of 
treatment and comparison 




7.6.2 Characteristics of Demographic Variables 
Table 7 Characteristics of Overall Sample for Continuous Items (N = 25) 
Characteristic M SD Min-Max 
Age (years) 73.52 8.45 56-87 
BMI 28.33 8.88 18.37-61.08 
Number of deliveries 3.44 2.55 0-12 
Age of onset of menopause (years) 50.67 6.64 40-65 
Length of urge incontinence symptoms (years) 7.97 9.81 3-50 
Number of prescription medications 3.36 2.01 1-8 
Daily caffeine use (serving) 1.33 1.44 0-4 
Types of physical health conditions reported .61 .94 0-3 
Types of mental health conditions reported .09 .29 0-1 
Types of medications reported .60 .65 0-2 
Note. Missing responses were noted for items: Age of onset of menopause (n = 3), 
number of prescription medications (n = 3), daily caffeine use (n = 1), physical health 
conditions (n = 2), and mental health conditions (n = 2). Age of onset of menopause had 





Table 8 Characteristics of Overall Sample for Categorical Items (N = 25) 
Characteristic n % 
Marital Status   
    Married 12 48.00 
    Other 13 52.00 
Ethnicity   
    Hispanic 3 12.00 
    Non-Hispanic 22 88.00 
Highest Educational Attainment   
    High school/GED or lower 3 12.00 
    Some college 6 24.00 
    Trade/technical/vocational Training 1 4.00 
    Associate degree  2 8.00 
    Bachelor degree 8 32.00 
    Master degree 4 16.00 
    Doctorate degree 1 4.00 
History of Pregnancy   
    Yes 23 92.00 
    No 2 8.00 
Life Satisfaction   
    Yes 24 96.00 
    No 1 4.00 
Life Stressors   
    Yes 6 24.00 
    No 19 76.00 
Current Medical Conditions   
    High blood pressure 9 36.00 
    Diabetes 4 16.00 
    Cancer 2 8.00 
    Heart problems 2 8.00 
    Major depression 1 4.00 
    Anxiety disorder 1 4.00 
Current Medication Use   
    Antidepressants or anxiolytics 7 28.00 
    Sleep medications 3 12.00 
    Pain medications 3 12.00 
    Beta-blockers 2 8.00 
Note. Missing responses were noted for diabetes (n = 1), cancer (n = 2), heart 




7.6.3 Differences in Baseline Characteristics between MBSR and  
HEP Conditions 
Table 9 Fisher’s Exact Test to Examine Differences in Categorical Baseline 
Characteristics Between MBSR and HEP Conditions (n = 13; n = 12) 
Baseline Characteristics MBSR HEP p-value 
 n (%) n (%) 
Marital Status 
    Married 









    White 









    Hispanic 





0 (0.00)  
12 (100.00) 
.22 
Highest Educational Level 
    Less than bachelor degree 








History of Pregnancy  
    Yes 
    No 
 







    Yes 









    Yes 













Table 10 Mann-Whitney U Tests to Test for Differences in Baseline Characteristics 
Between MBSR Versus HEP Conditions (n = 13; n = 12)  






 M (SD) M (SD) U z value 









52 -1.41 .16 




70.50 -.41 .68 






36.00 -1.28 .20 







76.00 -.11 .91 






46.50 -.93 .35 






65.50 -.39 .70 
Types of physical health 
conditions reported 
.38 (.65) .90 
(1.20) 
50.00 -1.07 .29 
Types of mental health 
conditions reported 
.08 (.28) .10 (.32) 63.50 -1.19 .85 
Types of medications 
reported 






7.6.4 Assumptions of Normality Associated with Outcome Measures 
Table 11 Analysis of the Assumptions of Normality on Outcome Measures  
Outcome measures Normality 
Yes No 


















W g1, Q-Q g1 
 
skewness, S-W 
g 2, Q-Q g2 
 
 





S, S-W g2 
 
histogram g1, 
K-S, S-W g1, 
Q-Q 
 





W g2, Q-Q g2 
 
histogram, S-W 
g1, Q-Q g1 
 







7.6.5 Overall Intervention Results of Outcome Measures 
Table 12 Analysis of the Effect of MBSR Versus HEP on Outcome Measures 
Outcome Measure Paired t test (df 
= 23) 
p value Wilcoxon 
Signed Ranks 
p value 
 Test Statistic (t) Z 
ISI 4.32 .000 -3.27 .001 
OAB-q complete (bother) 5.55 .000 -3.97 .000 
OAB-q Part 1 (informal 
severity) 
-.78 .222 -.015 .494 
OAB-q part 2 (bother) -5.44 .000 -3.94 .000 
PSS 2.34 .014 -2.03 .021 
GSE-UI -2.26 .016 -1.99 .023 




7.6.6 Within Group Results using Paired t Tests and Wilcoxon Signed Ranks Test 
Table 13 Within Group Results Using Paired t tests and Wilcoxon Signed Ranks Test (MBSR condition) 
Outcome 
Measure 
MBSR Paired t test Wilcoxon Signed Ranks Test 
Pretest M (n = 12) Posttest M (n = 12) T df p Z p 
ISI 7.00 4.08 2.80 11 .009 -2.23 .011 
OAB-q 64.25 38.83 5.12 11 .000 -3.06 .001 
PSS 11.00 7.92 1.96 11 .038 -1.078 .140 
GSE-UI 71.83 88.33 -2.60 11 .013 -2.35 .010 
  
 
Table 14 Within Group Results Using Paired t tests and Wilcoxon Signed Ranks Test (HEP condition) 
Outcome 
Measure 
HEP Paired t test Wilcoxon Signed Ranks Test 
Pretest M (n = 12) Posttest M (n = 12) T df p Z p 
ISI 9.00 6.08 3.21 11 .004 -2.44 .008 
OAB-q 69.33 50.92 2.97 11 .007 -.258 .005 
PSS 13.58 11.67 1.28 11 .113 -1.42 .079 
GSE-UI 59.83 65.92 -.793 11 .222 -.510 .305 












Model 3                                                                                                                                   





















7.6.8 Between Group Results Using Independent Samples t Tests and Mann Whitney U Tests and Effect Size on Outcome 
Measures using Parametric and Nonparametric Tests 
Table 15 Effect Size and Power Analysis of Differences in Outcome Measures Between MBSR and HEP  
Using Independent Samples t test 
Outcome Measures MBSR HEP Independent Samples 
t tests 
Effect Size Power Analysis 
M SD M SD P Cohen’s d 
Incontinence Severity Index 
(ISI) 




























































































Table 16 Effect Sizes and Power Analysis of Differences in Outcome Measures Between MBSR and HEP Using  
Mann-Whitney U Tests 
Outcome Measures Test Statistic Standardized Test Statistic Sig. 1-tailed Effect Size 
 U Z value p value r 
ISI 46.5 -1.493 .07 .32 low 
OAB-q 105.000 1.907 .06 .73 strong 
OAB-q (part 1) 38.50 -1.94 .03 - 
OAB-q (part 2) 38.50 -1.94 .03 - 
PSS 49.5 -1.301 .10 .34 low 
GSE-UI 45 -1.560 .06 .31 low 



























The findings of this study support the feasibility of conducting a randomized 
controlled trial of complementary therapies to treat UUI in older women, as well as 
demonstrating short-term preliminary efficacy of these modalities. All goals and 
benchmarks of the two feasibility aims were achieved, despite the challenges of 
executing a clinical trial among older adult women with a sensitive chronic condition. 
Both the research feasibility aims of recruitment, retention, and the five categories of 
treatment fidelity (fidelity in study design, provider training, enactment of treatment 
skills, and treatment receipt) as well as the intervention feasibility aims—acceptability, 
tolerability, and treatment adherence were accomplished. This encouraging outcome 
suggests that while women and older adults remain underrepresented in scientific 
research, the recruitment and enrollment of older adult women with a sensitive condition 
into a clinical trial is both a worthy and attainable endeavor. Despite the organization of 
large national research centers, this underrepresentation in clinical trials, and 
subsequently in the literature, persists ("Barriers to women's participation in clinical trials 
and SWHR proposed solutions,"; Herrera et al., 2010; Mody et al., 2008; Provencher, 
Mortenson, Tanguay-Garneau, Belanger, & Dagenais, 2014). As such, this study has 
value simply from the examination of the older adult woman as  research participant.    
The PI posited that the MBSR arm of the intervention would have superior impact 
on outcome and process measures, including reduced severity, bother, and perceived 
stress, and increase of self-efficacy surrounding urinary incontinence, as well as the rate 
and trajectory of perceived improvement. The short-term preliminary efficacy analysis 
showed MBSR superior to HEP in reducing severity and bother with p values of .05 on 
both measures. However, these significant results were only seen when analyzing the 
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Overactive Bladder Questionnaire Short Form in its two parts, not overall. The 
preliminary efficacy analysis of the process measure, PGI-I, also showed statistical 
significance between MBSR and HEP. A trend was also observed that MBSR may 
achieve improvement faster than HEP, although, due to the smaller sample, statistical 
significance was not observed.  
The preliminary efficacy analysis did not support MBSR as superior to HEP in 
reducing severity or bother using the ISI, the validated full OAB-q, or in reducing 
perceived stress (measured by the PSS), or in increasing efficacy measured with the GSE-
UI when analyzing significance using p values. However, the effect sizes were moderate, 
with Cohen’s d values ranging from .47-.66. The findings, although not statistically 
significant, were notable, as each condition evaluated separately evidenced statistically 
significantly improvement in severity, bother, perceived self-efficacy, and perceived 
improvement. When analyzed as a total sample (N = 24), all outcome and process 
measures were statistically significant. This indicates that older adult women with urge 
urinary incontinence may improve using both of these treatment conditions.  
Lack of statistical significance, given the more robust effect sizes, is most likely 
due to small sample size, as is congruent with pilot study work. This is further verified 
when examining the PGI-I data, which, having more data points, yielded statistical 
significance and a truer picture of the difference between MBSR and HEP.  
Another main reason may be the study design of comparing two approaches that 
have a likelihood of working, rather than comparing one intervention with nothing. The 
chosen study design is responsive to the NIH’s 2008 call to provide an active comparison 
condition to MBSR studies that is of equivalent commitment and experience (Ospina et 
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al., 2008). The fact that MBSR was not statistically superior to HEP in this stage of 
research says as much about the value of HEP as the potential superiority of MBSR.  
Perhaps the most compelling finding in the study was that both MBSR and HEP 
reduced urinary incontinence symptoms in older adult women, suggesting that a 
combination of MBSR and HEP treatment elements may be yet more efficacious. A 
combination of therapies including MBSR and empirically derived elements of HEP may 
produce greater therapeutic change and will be the basis of further research to treat this 
complex condition whose highest prevalence occurs in the older adult female population.  
An impressive level of engagement was consistently seen in both subsamples. 
Treatment adherence was measured through attendance and homework completion. 
Typical adherence to treatment regimen rates in adults are 60-75% (DiMatteo, 2004a, 
2004b; Dunbar-Jacob & Schlenk, 2001). Attendance for the MBSR condition averaged 
95.96% and attendance for the HEP condition averaged 97.22%. Homework submission 
for the MBSR condition averaged 88.43%. Homework submission for the HEP condition 
averaged 89.57%. This is evidence of a desire to address a sensitive condition in this 
population as well as an underappreciated willingness of older adults to participate in 
clinical health care research. Even participants who stopped attending either MBSR or 
HEP courses returned for data collection at completion. In a second example, the entire 
HEP class willingly adapted to a different meeting day to accommodate an 







The next phase of this study specifies a 6-month follow-up, which was explained 
in consent and enrollment, and a reminder was given at intervention completion. Each 
participant, including those who withdrew from the course, will be invited to fill out the 
five measurements once more: the ISI measuring severity, the OAB-q measuring bother, 
the PSS measuring perceived stress, the GSE-UI measuring urinary incontinence self-
efficacy, and the PGI-I measuring trajectory of change. This phase also includes a 
recorded interview of open-ended questions to examine the phenomenological experience 
of the participants. This qualitative information will be supplemented by qualitative 
information gathered from participants when expressing their feedback regarding 
acceptability.  
These study findings support the merit of future research in larger scale and/or 
multisite trials. Future research will include a larger scale effectiveness trial. One of the 
successes of this study was to recruit older women. Given that momentum, the 
effectiveness study would also seek to include women of more diverse racial and ethnic 
heritage and a broader geographic distribution. Knowing that it is feasible to recruit 
women 65 and older, future studies would confine eligibility to age 65+, rather than 
postmenopausal status. Findings from this larger fully powered effectiveness study could 
also yield better instrumentation, specifically in the measurement of urge severity. 
In addition, development and evaluation of a combined MBSR and HEP therapy 
to address UUI in older adult women is hypothesized to produce higher efficacy across 
study domains, and merits further study. A subsequent analysis would be to combine 
MBSR treatment with evidence-based components of HEP. Combined use of MBSR and 
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identified HEP treatment elements has potential application to other chronic conditions 
associated with aging, blood pressure regulation, early stage cognitive impairment, and 
mobility risks such as dizziness, syncopy, and falls.  
 
8.2 Conclusion 
This feasibility study and randomized controlled preliminary efficacy trial have 
been described from design to final analysis. Information regarding prior scientific 
literature, theories influencing design, study rationale, and aims with research questions 
has been comprehensively provided. Additionally, trial design, sample size, eligibility 
criteria, study locations, intervention descriptions, measures, and data analysis with 
concordant results have been clearly outlined, congruent with CONSORT and SPIRIT 
standards for responsible research conduct and reporting.    
This study demonstrated the successful feasibility of conducting a study using 
nonsurgical, nonpharmacological, mind–body and educational therapies to treat urge 
urinary incontinence in older adult women, including women in their late 80s. This RCT 
also demonstrated short-term preliminary efficacy to various degrees in reduction of 
severity, bother, perceived stress and increase in perceived self-efficacy and perceived 
improvement. While the sample size was modest, as is consistent with pilot studies, it 
was a sufficient size to randomize participants into two treatment conditions, in which 
each treatment condition would provide a therapeutically appropriate size for each 
intervention design. The RCT structure provided rigor and reduced threats to validity.  




treating UUI in older adult women. Study findings contribute to our understanding of the 
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